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DNA loop formation, mediated by protein binding, plays a broad range of 
roles in cellular function from gene regulation to genome compaction. While DNA 
flexibility has been well investigated, there has been controversy in assessing the 
flexibility of very small loops. We have engineered a pair of artificial coiled-coil 
DNA looping proteins (LZD73 and LZD87), with minimal inherent flexibility, to 
better understand the nature of DNA behavior in loops of less than 460 bp. Ring 
closure experiments (DNA cyclization) were used to observe induced topological 
changes in DNA upon binding to and looping around the engineered proteins. The 
length of DNA required to form a loop in our artificially rigid system was found to be 
substantially longer than loops formed with natural proteins in vivo. This suggests the 
inherent flexibility of natural looping proteins plays a substantial role in stabilizing 
small loop formation.  Additionally, by incrementally varying the binding site 
  
separation between 435 bp and 458 bp, it was observed that the LZD proteins could 
predictably manipulate the DNA topology.  At the lengths evaluated, the distribution 
of topological products correlates to the helical repeat of the double helix (10.5 bp).  
The dependence on binding site periodicity is an unequivocal demonstration of DNA 
looping and represents the first application of a rigid artificial protein in this capacity. 
By constructing these DNA looping proteins, we have created a platform for 
addressing DNA flexibility in regards to DNA looping.  Future applications for this 
technology include a vigorous study of the lower limits of DNA length during loop 
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1.1 DNA: The Genetic Polymer 
 
The elucidation of the double helix as the underlying structure behind nature’s 
continuance symbolizes the birth of modern molecular biology and provided a new 
understanding of our genesis.  By enabling an astonishing level of fidelity between 
generations, the semi-conservative method of replication would appear a logical 
extension of DNA’s form. But this process requires the complete dissociation of the 
two helices, a task for which the structure of DNA is far from ideal.  For starters, 
DNA is a very long molecule, narrow in width, and has a fairly short helical repeat 
(10.5bp), meaning it is heavily twisted.  In a closed circle, such as a genome, pulling 
apart the strands for replication or transcription places immediate strain, in the form 
of over-twisting, on the remaining double stranded portion of the molecule. 
                          
Figure 1.1  Figure Ideal B-DNA depicting the structure of the double helix.  (A) Watson and 




The difficulties in separating the double helix over an entire genome were 
discussed by Watson and Crick almost immediately after their groundbreaking 
announcement of its structure (J. D. Watson & Crick, 1953a; 1953b). The double 
helix, a consequence of the conjunction of asymmetrical building blocks, demands a 
substantial amount of energy and protein regulation in maintaining the equipoise 
between being genetically accessible and structurally compact.   Indeed, while 
proteins possess a remarkable tendency to mutate their shape, function, and relative 
size, DNA has remained nearly static in all physical aspects except for length.  As 
organisms have grown in size and complexity over the eons, they have adapted to 
their burgeoning genome not by improving its underlying structure but rather by 
increasing and diversifying the proteins that organize and maintain it.  
Indeed, while proteins possess a remarkable tendency to mutate their shape, 
function, and relative size, DNA has remained nearly static in all physical aspects 
except for length.  As organisms have grown in size and complexity over the eons, 
they have adapted to their burgeoning genome not by improving its underlying 
structure but rather by increasing and diversifying the proteins that organize and 
maintain it.  From histones or H-NS proteins that compact it to topoisomerases and 
gyrases that balance its strain, DNA is a highly regulated polymer that is ultimately 
under the control of proteins.  Without a responsive and energetically demanding 
system to maintain this spatial organization, or topology of DNA, life could never 
have developed into the complexity observed today.   
The advent of modern sequencing technology is delivering a wealth of data on 




information has the potential to shower benefits on our civilization from the 
identification and elimination of genetic disorders to a unified theory of evolution.  
But the path from the genetic code to living organism is, like the molecule itself, 
hardly linear.  The networks of genes and intricate feedback systems required for 
development demand coordination that is only beginning to be understood. There is a 
marked disconnect between the two-dimensional nature of genetic sequence and the 
three-dimensional life form to which it gives rise. Like all DNA, the human genome 
measures 2 nm in width but has a length that is orders of magnitude greater (108 for 
Homo sapiens).  That this molecule serves its function while compacted to fit inside a 
6 µm nucleus, attests to the complexity of its protein-regulated structure and 
underscores the need to comprehend the mechanisms behind its order.  DNA 
structure, its topology, geometry, and geography, represent the foundation upon 
which genetic information is built, stored, and accessed.  If we cannot observe, 
predict, and ultimately control the structure of DNA, the acquisition of its entire 
sequence will remain a feat of limited application. 
1.2 DNA Topology: Maintaining Order Within a Cell 
The helical repeat of DNA, a direct property of the twisting nature of the 
double helix, dictates that, when in an aqueous environment, the two strands will 
cross one another roughly once every 10.5 bp. A second type of crossover event 
occurs when two separate double helix strands make a close approach at a node.  This 
element of structure is referred to as writhe.  As the molecule is compacted, the 
formation of these crossover nodes becomes increasingly common. Depending on the 




As illustrated in Figure 1.2, the frequency and geometry of nodes result in the 
quantitative value of writhe.  The amount of writhe reflects the degree of 
supercoiling, which is the underlying feature of DNA topology.   This essential 
component of compaction was first described in the 1960’s while studying the two 
structurally distinct forms of genetically identical polyoma virus DNA (Vinograd, 
Lebowitz, Radloff, Watson, & Laipis, 1965).  But if these two identical sequences of 
DNA had different structural features, there must be a way to quantify the difference.   
The means of quantifying the structural differences lies in the number of times 
the two strands cross each other through both helical repeat (the twist component) and   
               
Figure 1.2 Plectonemic supercoiled DNA illustration.  Each line represents double stranded 
DNA.  The contribution of writhe in supercoiling is quantified by the formation of both (+) 
and (–) nodes leading to an increase or decrease in the linking number, respectively 
 
through node formation (the writhe component).  If two ends of a linear fragment of 




are linked together by the number of times the strands cross, as per the helical repeat.  
This quantity must be an integer (as there are no partial crossovers in a closed circle) 
and represents the linking number of circular DNA lying in a plane.  But fixing DNA 
to two dimensions is not an element of the real world.  In fact, genomic DNA crosses 
over itself constantly in its natural environment.  These crossover nodes are also 
linked in a closed circle of DNA and, as such, can be added to the number of helical 
repeat crossing events to provide an absolute linking number (Lk) for any given 
closed circle of DNA.  DNA nodes, however, can have either positive or negative 
values depending on the orientation of the cross over.   
As illustrated in Figure 1.2, a positive node increases the overall Lk value, 
while a negative change in writhe and an overall decrease in the linking number.  
Because the absolute value of Lk cannot change without breaking one or both strands 
of DNA, the linking number is an excellent means of quantifying DNA topology.  As 
seen in Figure 1.3, plasmid DNA with populations that differ in their linking numbers 
can be easily resolved using agarose gel electrophoresis in the presence of an 
intercalating agent such as chloroquine.  That the linking number remains unchanged 
(ΔLk = 0) in a given closed circle of DNA, however, does not mean that the twist 
(Tw) and writhe (Wr) components remain static.  The two elements can be readily 
inter-converted according to the following formula: 
Eq.1        for ΔLk = 0, ΔTw = -ΔWr 
This ability to relieve torsional stress by converting it to writhe is essential but 
clearly insufficient for dealing with the topological strain that arises during 




means of changing the linking number such that overtwisting caused by the strand 
separation during replication can be relieved.  If the strands could break then the 
change in either or both the twist and the writhe would result in a change in the 
linking number according to the following: 
Eq.2    ΔLk = ΔTw + ΔWr 
It was suggested in 1954, that cells may use an approach where one or both 
strands of the helix are broken so that torsional strain may be relieved through 
untwisting (Delbrück, 1954).  Nearly two decades would have to pass before this 
theory could be validated when, in 1971, an enzyme termed the ω-protein was 
isolated from E. coli (Wang, 1971).  This enzyme, subsequently renamed DNA 
Topoisomerase I, possesses an ability to relax supercoiled DNA by nicking one strand 
and allowing it to rotate about the axis of the intact strand.  Because this enzyme 
facilitated the breaking of one of the strands, the linking number could be changed.   
 
Figure 1.3 Supercoiled DNA depicting various degrees of supercoiling resolved on agarose 
gel with chloroquine. To form a distribution of topoisomer products, plasmid DNA was 
incubated with Topoisomerase I for an increasing amount of time (lanes 5,6,7). This gel is 





This was a monumental achievement for the nascent field of DNA topology and 
represented the first of a large and complex class of topoisomerase enzymes.   
1.3 Balancing Supercoiling with Topoisomerase 
Though it is unsurprising that the topoisomerase class of enzymes exists, it is 
nonetheless fascinating to consider the many ways cells have evolved to maintain the 
topological balance throughout their genome.  The immediate need for supercoiling is 
obvious, compaction, and nearly all cells maintain their genome as negatively 
supercoiled DNA (left-handed nodes). This topological state is maintained by the 
ATP-dependent enzyme DNA gyrase (Topoisomerase IIA) in bacterial and by histone 
wrapping in eukaryotes (Camerini-Otero & Felsenfeld, 1977; Gellert, Mizuuchi, 
O'Dea, & Nash, 1976).  But chromosomal condensation is far from the only 
application of this structural phenomenon.  For example, transcription factor binding 
has been shown, in some cases, to be dependent on the degree of negative 
supercoiling at the promoter site (Lamond, 1985).  Furthermore, the opening of a 
transcription bubble by RNA polymerase II requires a degree of local untwisting and 
corresponding torsional strain that is compensated by the inherent negative writhe 
(Choder & Aloni, 1988).  Though a preponderance of organisms maintain 
homeostasis with negatively supercoiled DNA, those living in extremely high 
temperatures, such as members of the Sulfolobus genus, have evolved a reverse 
gyrase, whose ATP-dependent activity introduces positive supercoiling (Kikuchi & 
Asai, 1984).  While negatively supercoiled DNA aids in opening DNA for 




increasing the melting temperature to maintain genomic stability at very high 
temperatures.   
The essential function and ubiquitous activity of topoisomerases has made 
them viable targets for cytotoxic drugs.  Because DNA gyrase and the closely related 
Topoisomerase IV are both unique to the bacterial kingdom, inhibitors specific to 
their function, such as fluoroquinolones like Cipro, have been put to use as broad 
spectrum antibiotics (Maxwell & Lawson, 2003).  Work on inhibiting eukaryotic 
topoisomerases has led to clinical applications in anti-cancer trials, as Topoisomerase 
activity is essential for replication (Hande, 1998).  It is also possible that protein 
engineering work with Topoisomerases may prove useful in the future of genetic 
manipulation.  One could see value in a Topoisomerase that possessed binding 
specificity that would limit its function to a predetermined location on the genome.  
In gene therapy, a targeted sequence may be histone-bound and inaccessible. A 
reverse gyrase enzyme that could target the region and induce positive supercoiling 
could aid in displacing the histones and allowing access to the area of interest.  If we 
are to attain the ability to access and control genetic material on a level that stretches 
across the entire genome, topoisomerases may well play a pivotal role.  However, for 
all their influence on DNA topology, the topoisomerase enzymes lack sequence 
specificity and thus act globally.  In an event where topology must be controlled at a 
local level, such as the regulation of a specific gene, nature has adapted a second 
method of topological control, the DNA looping proteins.  Protein-mediated loop 




this approach offers specificity and reversibility and may serve an alternate platform 
to affect DNA structure by design.   
1.4 Looping Proteins and Their Influence on Topology 
The phosphate backbone of the double helix presents the molecule with 
several advantages within in a cell.  The negative charge it carries contributes 
favorably to its solubility and makes its diffusion through cellular membrane unlikely.   
For proteins seeking to have some effect on DNA, this charge density serves as a 
beacon.  It is not difficult to imagine how early peptides with dense regions of 
arginine and lysine could have first adapted to binding DNA.   From transcription 
factors, to histones, to DNA repair enzymes, proteins have evolved to interact with 
DNA to perform a myriad of functions.  As organisms evolved and their genomes 
expanded, proteins with DNA binding ability became increasingly valuable in the 
effort to maintain order.    
Supercoiled DNA can be viewed as energetically primed.  As discussed, it is 
easier to compact, transcribe, and replicate DNA that is negatively writhed.  This 
energy is locked in position because the linking number of DNA cannot change 
unless one or both of the strands are broken.  But DNA is not an infinitely stable 
molecule and the threat of single-strand nicking or double-strand breaks places the 
genome in structural peril.  Fortunately, proteins have adapted to protect against these 
common threats by forming loops to lock DNA in position.  DNA looping proteins 
are therefore able to create isolated regions of topology where the actions on regions 
are structurally separate from another.  In E. coli, electron micrographs were able to 




Bowen, 1976).This work, and others like it, led to the formation of the rosette theory 
to describe bacterial DNA structure.  While still not fully understood, loop formation 
throughout the prokaryote genome is a highly regulated phenomenon, managed by a 
number of key proteins such as H-NS and HU (Noom, Navarre, Oshima, Wuite, & 
Dame, 2007; Thanbichler & Shapiro, 2006).  Recently, it has been demonstrated that 
these topologically isolated domains can be achieved using natural looping proteins 
on engineered plasmids in vitro (Leng, Chen, & Dunlap, 2011).  These examples of 
proteins exerting topological control on DNA suggest that manipulating DNA in an 
exact manner at specific sequences in quite possible.  To date only natural looping 
proteins have been utilized to create topological domains using DNA engineered to 
incorporate specific binding sites.   Expanding the engineering application to include 
modified or synthetic DNA looping proteins could vastly increase the scope of this 
application. With appropriate engineering, such proteins could be harnessed for work 
in gene therapy delivery systems or replication halting chemotherapy therapeutics.  
1.5 Looping Proteins and Their Influence on Gene Regulation 
The compaction of DNA, a global event in principle, is managed, with few 
exceptions, by proteins that bind to DNA without regard for sequence recognition.  
Gene transcription, a process requiring access to a linear form of DNA, can be viewed 
as a local event and, in contrast, typically involves proteins that bind in a sequence 
specific manner.  Because both of these extremes must coexist for survival, the 
genome is in constant state of balance between a need for compaction and a need for 
expansion. As discussed, the mechanisms employed to spatially manage DNA are 




the required specificity implicit in regulating thousands of unique genes has led to an 
immense diversity of control mechanisms.  Leaving aside the discussion of signaling 
pathways that may add layers of complexity to gene regulation, the essence of 
transcription can be distilled to the notion of a genetic circuit, capable of being turned 
on or off.    
Early insight into this regulatory approach came in 1961, from Jacob and 
Monod and their work with E. coli.  They noticed that the expression of three 
proteins, β-Galactosidase, permease, and transacetylase was enhanced in the presence 
of lactose (Jacob & Monod, 1961).  They theorized that the expression of the three 
genes, now known as lacZ, lacY, and lacA from the lac operon, were activated by 
lactose and repressed by some unknown agent in the absence of lactose.   This agent 
was later identified as the lac repressor protein (LacI) whose own expression was 
coded by the lacI gene at the upstream portion of the lac operon.  Its repression 
activity was linked to its ability to bind specifically to region of DNA within the lac 
operon, where it blocked RNA polymerase from binding (Gilbert & Maxam, 1973; 
Gilbert & Müller-Hill, 1966).  Furthermore, the identification of two other local 
binding sites for LacI within the lac operon suggested possible DNA loop 
conformations in vivo and that these sites provided enhanced repression through 
cooperativity (Krämer et al., 1987; Oehler, Eismann, Krämer, & Müller-Hill, 1990).  
Looping was proven by a clever experiment that showed that repression levels of the 
regulated gene lacZ were dependent on the periodicity of the LacI binding sites 
(Bellomy, Mossing, & Record, 1988).  This experiment was further refined and the 




type operon (Müller, Oehler, & Müller-Hill, 1996).  Figure 1.5, taken from Muller et 
al. demonstrates looping by correlating repression activity with the helical repeat of 
DNA.  Amazingly, evidence of looping was observed at lengths down to 57.5 bp 
between operator sites.    
               
That looping existed and could occur at such small lengths led to an evolution 
of our understanding of the lac operon system.  Its newly uncovered complexity 
confirmed DNA looping to be a means of enhancing the regulatory power of proteins 
involved in gene transcription.   
While arguably the most characterized DNA looping protein, LacI is not alone 
in its mechanism.  Another E. coli transcription pathway, the Gal repressosome 
utilizes looping and wrapping of DNA around the gal repressor protein (GalR) in its 
regulatory role (Haber & Adhya, 1988).  This model is distinct from the lac operon in 
that a secondary protein, HU, is involved in binding and kinking DNA within the loop 
Figure 1.4 (From Müller et al., 1996) Repression levels of chromosomal lacZ expression 
with increasing spacing between the LacI operator sites.  The repression is shown to be 
dependent on the phasing of the operators sites and correlates to the helical repeat of DNA 




thereby providing enhanced stability (Geanacopoulos, Vasmatzis, Zhurkin, & Adhya, 
2001; Lewis, Geanacopoulos, & Adhya, 1999).   
The relatively recent technique, chromosome conformation capture (3C), in 
which chromosomal DNA is covalently cross-linked to bound proteins and then those 
interactions are mapped by digestion, ligation, and PCR, has provided a systematic 
approach to DNA looping in vivo and has begun to elucidate its frequency (Davison 
et al., 2012; Tolhuis, Palstra, Splinter, Grosveld, & de Laat, 2002; K. Yun, So, Jash, 
& Im, 2009).  The prevalence of looping in eukaryotes, and its capacity to exist over 
surprising large distances of tens or hundreds of kilobases, further underscores the 
significance of DNA looping as a means of spatial control within a cell.   
1.6  Implications of Looping Size and Synthetic Manipulation 
DNA looping over very large lengths, such as those discovered using the 3C 
method, must overcome entropic hurdles to bring together these distant sites.  The 
large lengths do mitigate the energetic cost of bending or twisting DNA, and it can be 
concluded that looping DNA many times longer than its persistence of 50 nm 
(roughly 150 bp) is independent of the geometry of the bound DNA (Hagerman, 
1981).   In contrast, looping events of much smaller scale, such as the 91 bp loop in 
the lac operon, require a far greater energetic cost as DNA become quite rigid at 
shorter lengths (Oehler et al., 1990; Shore & Baldwin, 1983a).  The existence of 
looping well under the persistence length, such as the formerly mentioned LacI-
mediated loop, has been explained, in part, by attributing a fraction of the energetic 
cost to flexibility inherent in the looping protein (Edelman, Cheong, & Kahn, 2003; 




is the case, the ability of the protein to assume multiple conformations stabilized the 
small loop (Rutkauskas et al., 2009).  The LacI protein, which is a tetrameric protein 
held together by a leucine-rich four-helix bundle (4HB), contains two regions of 
considerable flexibility: the hinge region separating the DNA binding domain from 
the N-terminal core domain and the proline-rich linker connecting the C-terminal core 
domain to the 4HB.  Recent work involving DNA fragments with inherent 
topological strain induced by poly-adenine tracts (A-tracts), suggests that both an 
open and closed form of LacI may form depending on the contour of the DNA 
(Haeusler et al., 2012). In mutation studies involving the spacing of the LacI operator 
and its effect on repression rates, it was found that loops could form in vivo at lengths 
as short as 57 bp (Müller et al., 1996).  Looping has been confirmed by the fact that 
repression levels depended on the periodic spacing of the operators and correlated to 
the helical repeat of DNA (Bellomy et al., 1988). This result is truly remarkable given 
that this represents distances slightly over one third the persistence length.   
A competing theory of enhanced DNA flexibility at short lengths has been put 
forth to alternately explain the existence of very small loops.  In this model, the 
formation of spontaneous kinks in DNA results in enhanced bending effects at short 
lengths.  The theory was supported using DNA cyclization experiments of very short 
lengths (85-105 bp) where uni-molecular, or cyclized products formed with far higher 
frequency than predicted by common models used to describe DNA behavior such as 
the Worm-like Chain (WLC) model (Cloutier & Widom, 2004; 2005; Wiggins et al., 
2006).  The ratio of the formation of uni-molecular products and bimolecular product 




and calculate its persistence length (Shore & Baldwin, 1983b; 1983a).  The 
spontaneous kink theory is currently a source of contention and the approach used to 
demonstrate it has been openly challenged (Du, Smith, Shiffeldrim, Vologodskaia, & 
Vologodskii, 2005).  A DNA looping protein could be used to investigate this short 
sequence enhanced flexibility, but only if the protein served as a rigid link between 
the bound DNA.  Naturally occurring looping proteins rely on inherent flexibility 
and/or additional DNA binding proteins to alter the loop topology and increase 
stability as seen in the lac operon and Gal repressosome (Becker, Kahn, & Maher, 
2005; Roy et al., 2005).  These natural adaptations result in such proteins being 
inapplicable for studying DNA flexibility in isolation.  Lacking availability of a 
preexisting rigid DNA looping protein, our lab set out to engineer an artificial 
alternative.   
1.7 Incorporating Rigidity into a DNA Looping Protein 
 
De novo protein design will, by definition, begin at the level of its building 
blocks.  Because this protein must meet certain structural specifications, namely 
uniform rigidity, forethought must go into how the amino acid sequence will 
ultimately fold.  Of the limited secondary structures observed in peptide folding, it 
seemed logical to commence with a comparison of their relative flexibility.  While no 
organic polymer with cellular origins can be considered truly rigid, as compared to 
macroscopic things such as lumber and steel, the relative stiffness of microscopic 
polymers can be rated using metrics such as persistence length.  The persistence 




polymer. As seen in equation 3, the free energy of bending is directly correlated to the 
persistence length, a, over the contour, L, with a total bend angle, ΔΘ (Kahn & 
Crothers, 1998): 





          
Molecular-dynamics simulations performed on peptides that consisted of a 
continuous α-helix concluded the structure to have a persistence length of 100 nm, or 
twice that of DNA (Choe & Sun, 2005). Furthermore, similar analysis on the structure 
of a coiled-coil of α-helices, like that in the leucine zipper motif, increased the 
persistence length to nearly 150 nm (Wolgemuth & Sun, 2006).  In contrast, the 
alternative secondary structure, β-sheets, in both parallel and anti-parallel form, were 
computationally shown to be significantly more flexible, with the frequent turns 
facilitating bending deformations (Choe & Sun, 2007; Emberly, Mukhopadhyay, 
Tang, & Wingreen, 2004).  Random coil secondary structure was not considered for 
our application.  The leucine zipper motif is a well-characterized coiled-coil structure 
of α-helices.  Of the natural structures available to serve as a template for our initial 
design, it was believe to offers the greatest potential for incorporating rigidity into a 
DNA binding protein.    
Cortexillin is an actin-bundling protein in Dictyostelium discoideum that plays 
a major role in cellular shape, chemotaxis, and chromosome separation (Faix et al., 
1996; Gerisch, Faix, Köhler, & Müller-Taubenberger, 2004).  One of its most 





Figure 1.5 (A) The 101 aa structure of cortexillin in dimer form is a continuous coiled-coil 
motif.  (B) The sequence highlights the hydrophobic elements of the a’ and d’ positions of the 
helical repeat, blue and red, respectively (also shown in space filling form in (A)).  Image 
produced using Pymol, structure reference PDB:1D7M.  
 
This region has been frequently used to study coiled-coil structure and played a major 
role in deciphering the amino acid trigger-sequence that dictates the oligomerization 
state in coiled-coil structures of two or more helices (Ciani et al., 2010).  Figure 1.5 
was generated using the crystal structure solved by Burkard and colleagues and 
illustrates the large coiled-coil feature of coxtexillin (Burkhard, Kammerer, 
Steinmetz, Bourenkov, & Aebi, 2000).  Like nearly all coiled-coil dimers, cortexillin 
associates in a parallel orientation and displays a left-handed geometry along the 
helical axis.  The crystal structure has been used to calculate a rotational period of 
roughly 49 aa (or 7 heptad repeats) for every 180° of twist.  This rotational feature 
was taken into consideration when designing the length of our looping proteins and 
its effect on binding site orientation.   
1.8 DNA Binding with Basic Leucine Zipper Proteins (bZip) 
 
The bZip structural motif is a DNA binding domain used in a class of 




(Amoutzias et al., 2007). Because the leucine zipper is a coiled-coil structure, use of a 
bZip DNA binding domain is appealing in the design of a rigid DNA looping protein.  
In an effort to minimize the potential for flexibility, the peptide structure should be 
continuous in nature, meaning that the coiled-coil motif is to be maintained for all, or 
nearly all of the structure. c-Myc is a DNA binding protein found in humans that was 
first identified by way of its sequence similarity with the oncogene v-Myc from the 
avian myelocytomatosis virus (Dalla-Favera et al., 1982).  Structurally this protein is 
significant because its similarity to CCAAT-enhancer binding protein (C/EBP), 
specifically the placement of leucine residues at the d position of the heptad repeat 
(abcdefg) over the span of four helical repeats, led to the discovery of the leucine 
zipper motif and its recurrent association with DNA binding regions (Landschulz, 
Johnson, & McKnight, 1988).  Further characterization of the structure uncovered the 
importance of the electrostatic interactions between the e and g’ residues between 
helices in providing stability and dimerization specificity (O'Shea, Lumb, & Kim, 
1993; O'Shea, Rutkowski, & Kim, 1992).  As seen in Figure 1.6, the dimerization of 
the GCN4 homodimer is stabilized by the hydrophobic interactions of the a and d 
residues of one α-helix with the a’ and d’ residues of its pairing α-helix.  
Additionally, electrostatic interactions of the e residues of one helix with the and g’ 
residues of the helix lead to greater stability.  To the N-terminal of the leucine zipper, 
the DNA binding region of this motif makes frequent use of the basic amino acids 
lysine and arginine as contact points with the DNA phosphate backbone. It is the 




broad class of DNA binding proteins being referred to as the basic leucine zipper, or 
the bZip family.   
 
Figure 1.6 A graphical representation of the residue interactions of the GCN4 leucine zipper.  
Left, an α-helix diagram depicting the hydrophobic burying of the a and d residues in the 
coiled-coil.  Right, a space filling illustration showing both the hydrophobic burying of the a 
and d (red and blue spheres) as well as the interaction between the g and e’ residues between 
alpha helices (green and yellow spheres). 
 
There exists a great deal of variety among the bZip members.  All are capable 
of dimerization but many, such as the human fos/jun pair as heterodimers (Abate, 
Luk, Gentz, Rauscher, & Curran, 1990), while others such as the yeast factor GCN4 
form homodimers (Ellenberger, Brandl, Struhl, & Harrison, 1992; O'Shea, 
Rutkowski, Stafford, & Kim, 1989). Among the DNA binding regions there also 
exists a degree of structural variance.  Previous work with c-Myc suggested that it 
was capable of forming a tetramer that could bind DNA at two points to form a loop 
(Ferré-D'Amaré, Pognonec, Roeder, & Burley, 1994). While the rigidity of such a 
structure was unknown, it presented an interesting approach to how coiled-coils could 
incorporate two DNA binding regions.  c-Myc, as a rigid looping protein, had several 




Loop-Helix motif for the transition from the helical binding region to the helical 
zipper domain (Fisher, Parent, & Sharp, 1993). This structural feature was then 
demonstrated in the solved crystal structure as a heterodimer with its protein 
counterpart Max (Nair & Burley, 2003).  Here, the loop region junction likely plays a 
role in stabilizing the interaction and enhances the binding but may afford the protein 
flexibility and as such should be avoided in our design.  Moreover, recent work with 
c-Myc and its sometimes dimerization partner Max demonstrated that while the 
proteins could fold in a matter that allowed for binding two strands of DNA, in a 
structure termed a “sandwich complex”, the binding was found to be too weak to 
support the formation of a DNA loop (Lebel, McDuff, Lavigne, & Grandbois, 2007).  
This prior work would exclude c-Myc from further consideration in the design 
process, but it was illuminating in suggesting a route to combine two DNA binding 
sites along a coiled-coil motif. 
The yeast transcription factor GCN4 was identified by its association with the 
His3 gene and its role in regulating amino acid biosynthesis during periods of 
starvation (Hope & Struhl, 1985).  Further analysis indicated that it bound to DNA in 
dimeric form (Hope & Struhl, 1987).  The following year, the c-Myc & C/EBP 
correlation led to the announcement of the bZip family motif and it was quickly noted 
that the DNA binding region of GCN4 aligned with this proposed structure.  The 
structure of the leucine zipper region of the protein was then solved in 1991, which 
solidified its status in the bZip family (O'Shea, Klemm, Kim, & Alber, 1991). The 
complete bZip domain bound to the pseudo-palidromic AP1 DNA (5’-




continuous stretch of α-helices extending from the coiled-coil region straight through 
the DNA-binding site (Ellenberger et al., 1992).  An additional structure (depicted in 
Figure 1.7), solved by Tom Richmond’s group, shows GCN4 bound to the 
palindromic CREB DNA (5’-ATGACGTCAT-3’).  This structure was solved to a 
higher resolution enabling accurate characterization of the Protein:DNA contact 
 
Figure 1.7 The crystal structure of GCN4 bZip domain illustrates a continuous α-helical 
structure between the coiled-coil and the DNA binding site.  The continuous α-helix is 
intended to confer rigidity to the proteins. Image created using Pymol with PDB:1DGC 
 
points (Keller, König, & Richmond, 1995). This work was able to provide a contact 
map fully elucidating the interaction between one of the α-helices and half of the 
palindromic binding sites.  This is depicted in Figure 1.8, taken from Keller, et al. 
1995. The continuous extension of α-helical structure between the coiled-coil region 
and the basic DNA binding site is of particular interest because this structure confers 




GCN4 was, therefore, selected as the starting template for our artificial DNA looping 
protein.  For a means of combining two DNA binding-sites our design turned 
elsewhere.   
  
Figure 1.8 (From Keller et al, 1995) The contact mapping between the α-helical region of the 
GCN4 monomer and the CREB site DNA (half-binding site). (A) a grid depiction of amino 
acids forming bonds with DNA base pairs (b-direct to base, w-through water to base, p-direct 
to phosphate backbone, x-via water to phosphate backbone.  (B) Visual contact map of these 
bonds. 
   
Increasingly, engineers have looked to biomimetics to provide solutions to 
medical challenges from tissue regeneration to gene delivery (Chae et al., 2011; 
Coburn et al., 2011). For applications that require in vivo DNA manipulation, protein-




of size possibilities and the incorporation of highly specific sequence recognition, 
such a system offers tremendous potential for eliciting control over DNA.  It will 
undoubtedly take a great deal of bioengineering to convert a looping concept into a 
clinical reality, but it can begin with a simple statement of purpose: design an 
artificial DNA looping protein and investigate how it can manipulate DNA structure.  
This thesis describes the design, purification, and expression of a series of artificial 
proteins (Chapter 2) the binding characterization of the various peptides (Chapter 3), 
evidence of transient DNA loop formation (Chapter 4), and subsequent analysis of the 
topological manipulation induced by loop formation with our proteins (Chapter 5). By 
creating an artificial DNA looping protein, we have created a platform for affecting 
DNA topology by design.  Additionally, the binding-site specificity and ability of the 
protein to alter the DNA binding site orientation through design modifications makes 
this work potentially well suited to developing self-assembling protein:DNA 














2 Chapter 2: The Design, Expression, and Purification of 





2.1 The Coiled-Coil Rigid DNA Looping Protein 
 
The argument for using the coiled-coil structure in designing a rigid DNA 
looping protein is presented in sections 1.7 and 1.8.  The application of this concept 
resulted in two major design approaches: a tetrameric design and dimeric design.  
Both of these structures would be assembled using homodimers with GCN4 DNA 
binding domains.  Future work with this project may find the use of hetero-
multimeric assembly appealing, as this would provide greater variety to the DNA 
binding sequence, which in our design is limited to palindromic sequences. Such a 
design was not considered in our application here.  This chapter will describe the 
design and synthesis of the tetrameric and dimeric DNA looping protein designs used 
in this project.    
2.2 Design of a Tetrameric DNA Looping Protein 
The LacI DNA looping protein folds into a stable tetramer as a dimer of dimers, 
in which dimeric core domains are held together by a leucine-rich four-helix bundle 
(Alberti, Oehler, Wilcken-Bergmann, & Müller-Hill, 1993; Alberti, Oehler, Wilcken-
Bergmann, Krämer, & Müller-Hill, 1991).  Crystal structure analysis of the core and 
tetramerization domains revealed that the 4HB domain, in which the helices are 
arranged in an anti-parallel orientation, positions the N-terminal ends to lie slightly 
farther apart that the helices found in leucine zipper dimers (Friedman, Fischmann, & 
Steitz, 1995).  Structural studies involving the folding of leucine heptad structures 




could interconvert the ultimate oligomeric state (Betz, Liebman, & DeGrado, 1997; 
Noom, Navarre, Oshima, Wuite, & Dame, 2007; Oakley & Hollenbeck, 2001; 
Thanbichler & Shapiro, 2006).  These observations combined with the earlier 
suggestiion that c-Myc/Max could form a tetramer, albeit an unstable one, lead us to 
design a bridge to combine two GCN4 bZip regions with a LacI 4HB.  
 
Figure 2.1 Assembly of the tetrameric DNA looping design with two GCN4 DNA binding 
domains (green) fused with the LacI tetramerization domain (cyan) and incorporating a short 
linker sequence (magenta) to preserve the α-helical repeat.   
 
Figure 2.1 illustrates the putative assembly of the designed tetrameric looping protein.  
The inability to exactly fit the junction between the 4HB domain (cyan) and the  
         
Figure 2.2 Schematic illustrating the assembly of the tetrameric DNA looping proteins using 
the LacI 4-helix bundle (light blue) and the GCN4 dimeric bZip domain (dark blue).  The 
kitty-corner positioning of the 4-helix bundle provides a transition from tetrameric to dimeric 





GCN4 coiled-coil (green) was addressed by incorporating a heptad repeat linker -
(magenta) to allow the coiled-coil helices to partially separate as they transitioned to 
the 4HB.  Figure 2.2 is a schematic representing the assembly of the tetrameric DNA 
looping proteins.   
The dense packing of hydrophobic residues in an extended leucine zipper may 
present solubility issue for our peptides.  To account for the possibility of an insoluble 
product and the unknown element of transitioning between a coiled-coil and 4HB 
domain, four mutants were designed where each incorporated a unique linker.  Genes 
expressing these four mutants were synthesized and cloned into plasmid pRSETA by 
 
Figure 2.3 Modular assembly of the 4-helix bundle (4HB) proteins (A).  Sequences given for 
the 4 constructs with the various domains underlined according to purpose: yellow – common 
N-terminal 6X histag and Enteropeptidase site (dashed underline), red – basic binding region, 
green – leucine zipper region, magenta – linker, blue – 4 helix bundle region.   
 
Jason Kahn, expressed and purified as described in section 2.4.  Figure 2.3 illustrates 





2.3 Design of the Dimeric Looping Protein 
As indicated in Figure 2.3, three of the four tetrameric constructs expressed as 
insoluble peptides.  This conclusion is taken from SDS PAGE analysis of the soluble 
lysis and insoluble pellet done during purification (Figure 2.8). While purification of 
these peptides was achievable using 6 M guanidine, efforts to refold the proteins upon 
removal of the guanidine proved unsuccessful.  Additionally, binding analysis of the 
soluble LZEE construct provided evidence that the protein was not folding into a 
tetrameric state capable of binding two DNA fragments (see section 3.2.1).  
It was thereby necessary to develop a second approach to designing an artificial 
looping protein.  This subsequent engineering effort was more an extension of the 
previous design rather than a complete restructuring.  The arguments for the coiled-
coil motif conferring rigidity were sound and the strong binding of the GCN4 basic 
binding site had no shortcomings.  The problem resided with the tetrameric domain 
and the likely possibility that dimerization rather than tetramerization of LZEE 
resulted in a more stable structure.  Instead of a tetrameric linking domain we turned 
to a simpler assembly, a dimeric leucine zipper dual-binding (LZD) protein. 
2.3.1 The reverseGCN4 DNA Binding Protein 
The inspiration for the next step came from work on the GCN4 peptide by 
Martha Oakley.  Her group’s investigation into the folding of bZip peptides led her to 
ask whether there was an inherent thermodynamic reason that all bZip DNA binding 
proteins position the basic region to the N-terminal side of the leucine zipper domain 




only be described as essential to this project, her lab reconstructed the GCN4 peptide 
by inverting the order of the two domains and positioning the binding region at the C-
terminal of the peptide, as illustrated in Figure 2.4.   
        
Figure 2.4 Modular assembly of reverseGCN4 created by Hollenbeck and Oakley (2001).  
The reversal of positions of the basic binding region (yellow) and the leucine zipper region 
(green) was performed to access whether there was a thermodynamic reason for the evolution 
of the N-terminal basic region arrangement among natural bZip DNA binding proteins. 
 
The protein was simply named reverseGCN4 or rGCN4.  To avoid confusion 
with recombinant nomenclature, it will only be referred to here as reverseGCN4.  
Empirical work with the α-helical phasing of the basic regions with respect to the 
leucine zipper using binding assays involving DNA with variants of an inverted 
CREB site produced a peptide that could bind DNA with near wild-type affinity (Kd 
= 29 nM). The mutated binding site sequence Inv-2 (5’-GTCATATGAC-3’) resulted 
in the highest affinity and was a perfect inversion of the GCN4 specific CREB site 
(5’-ATGACGTCAT-3’).  The successful protein mutant utilized a 7 aa linker (-
LQKLQRV-) between the GCN4 leucine zipper and the now C-terminal basic 




binding regions, preserves the previously determined DNA interaction maps. A model 
of the reverseGCN4 peptide is depicted in Figure 2.5 along with the GCN4 bZip 
peptide. 
 
Figure 2.5 The two DNA binding domains that will be fused to form the leucine zipper dual-
binding (LZD) protein.  Left, the N-terminal domain binds specifically to CREB DNA (from 
Keller et al. 1995 – rendered in Pymol PDB:1DGC).  Right, the C-terminal domain binds 
specifically to Inv-2 (Inverted CREB) DNA (image is a Pymol generated illustration). 
 
This design should not be confused with work that reverses the sequence of 
amino acids from C to N-terminal.  This structural change has previously been done 
with the leucine zipper sequence of GCN4 in creating a retroGCN4 peptide, which 
folds into a stable 4-helix bundle (Mittl et al., 2000).   
The reverseGCN4 artificial protein presented a perfect opportunity to simplify 
our looping protein into a dimeric structure.  By fusing the GCN4 bZip peptide with 
the reverseGCN4 peptide sequence the folded dimer should contain two DNA 
binding domains.  The amino acid sequence separating the two binding sites was 
determined by aligning the reverseGCN4 sequence with GCN4 bZip resulting in a 73 




the C-terminal binding site.  The protein design was termed LZD73.  A gene 
expressing this peptide was cloned into pRSETA that incorporated an N-terminal 6X 
his-tag and Enteropeptidase cleavage site (-DDDKD-).  The left-handed geometry of 
the coiled-coil motif presented a unique opportunity to adjust the angles between the 
two DNA strands. Because the coiled-coil wraps around itself and the binding site of 
the DNA is perpendicular to the coiled-coil axis, an extension of the coiled-coil 
should result in a change in the relative binding. To investigate this possibility, a 
second looping protein mutant was designed to incorporate an additional 14 amino 
acids between the GCN4 leucine zipper and the reverseGCN4 linking sequence. 
Keeping with the nomenclature established with LZD73, the additional 14 amino 
acids is reflected in the name LZD87.  An N-terminal overlap of models for LZD 73 
and LZD87 bound to CREB and Inv-2 DNA is depicted Figure 2.6.  
 
Figure 2.6 Overlay of renderings for LZD73 (green) and LZD87 (blue) DNA binding proteins 
bound to 20 bp DNA with either CREB or Inv-2 site sequence at the N-terminal and C-
terminal, respectively.  Pymol image illustrates the coiled-coil left-handed orientation and 





The effects of the addition of 14 amino acids can be seen in the change in binding 
orientation of bound DNA segments.  
Figure 2.7A illustrates the modular assembly of these two genes and 2.7B lists 
the amino acid sequence for each.  By extending the leucine zipper domain by two 
heptad repeats, the hydrophobic content of the peptide was increased.  
 
Figure 2.7 The modular assembly of LZD73 and LZD 87 proteins. (A) A depiction of the 
fusion of two basic DNA binding domains by a continuous coiled-coil domain and the 
necessary C-terminal linker region (H/O linker) determined in Hollenbeck and Oakley, 2001. 
(B) Sequences used in the design with the underlined regions corresponding to the modular 
illustration depicted in (A). 
 
The solubility problems encountered in the 4HB mutant work raised concerns 
that this might lead to similar folding difficulties. In order to maximize the likelihood 
that this mutant would be soluble, the 14 aa sequence was taken directly in frame 
from LZEE, the soluble 4HB peptide. For visualization purposes, two models were 
generated using Pymol (see Figure 2.6). This image is meant to be illustrative and 
does not reflect any knowledge of the actual binding site angle orientation. In the 
figure above, the N-terminals have been aligned to highlight the binding site 




2.4 Expression of 4HB and LZD proteins 
All reagents were purchased from Fisher Scientific with the exception of [γ-
32P]-ATP, which was purchased from Perkin Elmer.  Polynucleotide kinase was 
purchased from New England Biolabs (NEB).  Protein chromatography was 
performed on the AKTA FPLC using columns purchased from GE Healthcare.  
Centrifugal filters were purchased from Millipore.  Bio-spin 6 columns were 
purchased from Bio-Rad. 
2.4.1 4HB Mutant Expression 
Each of the four 4HB sequences denotaed previously were prepared by 
oligonucleotide synthesis and mutually primed extension to give the plasmids 
pLZEE, pLZAR, p4HEE, and p4HAR.  The expressed sequence contained an N-
terminal  6X histidine tag for metal chelate affinity purification as well as an 
Enteropeptidase binding/cleavage sequence (-DDDDKD-) between the his tag and the 
4HB open reading frame.  The plasmids were transformed into electrocompetent 
BL21 DE3 (pLysS) cells by electroporation.  The ORF sequence for each of these 
proteins is found in Appendix A.  After rescue with SOC (1 mL) and 1 hr at 37 °C 
with shaking, the cells (15 µL) were streaked on LB agar containing ampicillin (100 
mg/L) and chloramphenicol (40 mg/L).  The plates were then incubated overnight at 
37 °C.  A single colony was selected the following day and expanded overnight in a 5 
mL LB culture (+Amp/+Cam) with agitation, at 37 °C. The culture was then used to 
inoculate a pre-warmed 1 L LB (+Amp/+Cam again) solution in a 4 L Erlenmeyer 
flask in the morning and allowed to grow for 4-6 hours until the optical density 




the cells were allowed to express for 3 hours. The cells were harvested by 
centrifugation for 15 minutes at 12,000 x g and the wet pellets were frozen and stored 
at -80 °C unless purification was immediately implemented.  Typical yields for 1 L 
harvests in this procedure were 2.0-2.5 g cell paste (wet).   
2.4.2 LZD Mutant Expression 
Plasmids containing the sequences coding for LZD73, LZD87, and the single 
binding C-terminal control reverseGCN4 were transformed into E. coli BL21 DE3 
(pLysS) cells, selected for expansion and then grown in 5 mL starter culture as 
described for the 4HB mutants.  Because of slower growth relative to the previous 
mutants, the timescale for pre-induction growth and expression length was adjusted 
accordingly to maximize yield. This retarded growth for cells carrying the LZD 
protein genes is likely due to leaky expression of the high-copy pRSETA expression 
system.  It can be inferred that the LZD proteins are toxic for the host cells.  It is 
possible that use of pLysE in place of pLysS could increase the growth rate during the 
pre-induction stage.  Relative to pLsysS, pLysE has a higher expression of T7 
lysozyme, which binds to and inhibits T7 RNA polymerase.  The basal expression of 
T7 RNA polymerase during pre-induction growth leads to leaky expression of the 
target pRSETA-based gene, and the leaky expression of a toxic protein is the likely 
cause of the diminished growth rate.   For pre-induction growth, the 5 mL starter 
culture was used to inoculate 1 L of 37 °C LB that had been pre-warmed overnight.  
This step is performed early in the morning, because growth is very slow at this step.  
After 10 hours of shaking at 37 °C, the cells typically have reached an OD600 




mM) and the protein was given an extended, 18 hr, expression time (overnight).  The 
following morning, the cells were harvested as performed for the 4HB mutants.  
Yields of cell paste (by weight) were similar to those of the 4HB despite the total 
growth time being more than doubled. 
2.4.3 Extraction and Purification of 4HB Proteins 
 
A typical purification scheme begins with 1.5 g cell paste.  The cells were 
thawed and resuspended in 20 volumes (30 mL for 1.5 g cell paste) of lysis buffer (10 
mM MES pH 6.0, 0.5 M NaCl, 20 mM imidazole) and ruptured by French Press (3 
passes) under 15,000 PSI, with ice bath chilling.  Care must be taken to ensure a slow, 
drop–wise, use of the French Press, as haste leads to poor lysis quality. The lysate 
was then centrifuged for 30 minutes at 22,000 x g and the soluble supernatant 
decanted and filtered through 0.2 µm membrane syringe-based disc filter (Whatman) 
prior to chromatography.  Analysis of the lysis material (soluble supernatant and 
insoluble pellet) revealed that only LZEE was soluble upon lysis. 
  
Figure 2.8 Expression of the 4HB constructs.  Each expression sample is shown at pre-
induction (0 hr) and after 3 hr induction with IPTG [0.5 mM].  The samples were lysed and 




Figure 2.8 shows the expression and insoluble nature of 4HAR, 4HEE, and 
LZAR, which all appeared in the insoluble pellet.  LZEE expression could not be 
confirmed in the experiment shown in Figure 2.8 (left gel).  Expression was 
subsequently confirmed during analysis of the chromatographic purification (see 
Figure 2.9). It is possible that the low level of expression of LZEE improved 
solubility or that the expression of a DNA binding protein inhibited expression.  
Work done by others to express LZEE cloned into pBAD, which uses a regulatable 
expression system, ultimately failed.   
Because of the difference in solubility, the process bifurcated such that LZEE 
was processed by chromatography directly from the lysis buffer, while LZAR, 4HEE, 
and 4HAR were processed in 6 M guanidine.  For a detailed protocol of the one step 
purification run using the AKTA FPLC and representative chromatograms, see 
Appendix 2.  The buffer composition for the LZEE chromatography run was as 
follows:  
 
Equilibration – 10 mM MES pH 6.0, 0.5 M NaCl, 20 mM imidazole.   
Elution – 10 mM MES pH 6.0, 0.5 M NaCl, 0.4 M imidazole.   
 
The three insoluble pellets were resuspended in the following equilibration 
buffer containing 6 M Guanidine and then centrifuged again at 22,000 x g for an 
additional 30 minutes.  The buffer composition for the purification protocol was as 
follows: 
 
Equilibration – 10 mM MES pH 6.0, 6 M Guanidine, 0.5 M NaCl, 20 mM imidazole.   





Purification of each protein was achieved using single step affinity 
chromatography using Co2+ charged HiTrap Chelating 1 mL column (GE Healthcare) 
Cobalt Acetate [0.2 M] was the typical solution used to charge the column.   
Following the load application to the column, a 5 column volume (CV) wash was 
performed using Equilibration buffer.  The protein was eluted by a 25 CV 
Equilibration-Elution Buffer gradient from 20 mM to 400 mM Imidazole. The eluent 
was collected in 1 mL fractions which were analyzed by SDS PAGE on 20 % 
acrylamide gels (75:1 acrylamide to bis-acrylamide ratio) run using a tricine/SDS 
buffering system for 1 hr at 120 V.  For a representative chromatogram from the 
HiTrap Co2+ Chelating step see appendix 2. The typical elution fractions (C1-C5) 
have been highlighted in the chromatogram, though SDS PAGE analysis is always 
required to confirm purity. 
 
                                  
Figure 2.9 Analysis of LZEE purification steps using HiTrap chelating affinity column 
purification with Co2+ metal.  The gel analysis shows the whole cell lysis (WC), the insoluble 
pellet, the soluble load, the flow through, and then selected elution fractions B12-C2, 
corresponding to approximately [240-260 mM] imidazole, showing the target LZEE protein.  





Following the chromatography run, the columns could be regenerated for 
future use by stripping the divalent metal with 0.05 M EDTA followed by a 1 hr 0.5 
M NaOH cleaning step, water rinse and reapplication of the Co2+ solution.  Typically 
purification performance began to noticeably diminish after only 5 runs, although the 
manufacturer attests to far more column cycles.  Due to the relatively low cost of 
these columns, discarding after 5 runs is the wiser option.   
                          
Figure 2.10 Analysis of LZD 73 purification steps using HiTrap chalating affinity column 
purification with Co2+ metal.  The gel analysis shows the load, the flow through (FT) and 
selected elution fractions B8 and C3-C8, corresponding to approximately [240-270 mM] 
imidazole.  
  
2.4.4 Concentration and Buffer Exchange into Storage Buffer 
For the soluble proteins (LZEE, LZD73, LZD87, and reverseGCN4), peak 
fractions were pooled into 4 or 5 mL batches depending on SDS PAGE analysis.  The 
4-5 mL batches were concentrated to approximately 100-200 µL using a Centricon 
Ultra 4000 (Millipore), by centrifuging for 30-60 minutes at 10,000 x g depending on 
the batch.  Peptides purified prior to August, 2010 were buffer exchanged and stored 
in 10 mM Tris HCl pH 7.7, 150 mM NaCl, and 10 % Glycerol or else 50 mM 




Batches after August, 2010 were buffer exchanged into a storage buffer of 20 mM 
HEPES pH 7.0, 150 mM NaCl, 10 % Glycerol using a Biospin 6 column that had 
been prepared by flushing with 4 X 500 µL flushes of storage buffer.  The switch to 
HEPES buffer in August, 2010 was made because Tris buffers are knows to inhibit 
potential cross-linking reactions and the acetate based buffer yielded proteins with 
lower binding activity. Samples were stored at -80 °C where they were shown to 
remain actuve for at least 24 months.  Samples that were subjected to freeze/thaw 
cycles saw an immediate decrease in activity and were virtually inactive after three 
cycles.   
Insoluble proteins were stored in elution buffer containing 6 M Guanidine.  
Attempts to buffer exchange these proteins into less chaotropic buffers such as 0.5 M 
arginine resulted in precipitation.  Prior to their use in EMSA experiments, they were 
diluted to working concentration in 1X binding buffer.  While this method carried the 
risk of leading to a precipitation, it was hoped that at very low concentrations [≤100 
nM], the protein would fold into a soluble state without aggregation. 
Protein concentrations were primarily determined by UV260 absorption using the 
estimated extinction coefficient of 8480 M-1cm-1 as calculated using Expasy Protein 
Parameter analysis of the peptide sequences.  Concentrations were also confirmed by 
gel analysis using SYPRO Ruby stain, where protein samples were fit to a BSA 
standard curve, using spot quantitation on the Storm Imager (Molecular Dynamics) to 





2.4.5 Circular Dichroism Analysis of LZD73 
 
The α-helical content of LZD73 peptide was analyzed by circular dichroism 
(CD) spectroscopy.  The LZD73 sample was buffer exchanged into a buffer 
optimized for Enteropeptidase digestion (20 mM Tris-HCl (pH 8.0 @ 25°C), 50 mM 
NaCl, 2 mM CaCl2) in anticipation that the N-terminus of the protein might need to 
be removed.  However, the CD was done on uncleaved protein.  Analysis of the 
LZD73 protein at [1.2 µM], in the absence of DNA, using the buffer alone as 
background, is shown in Figure 2.11A.  For the protein plus DNA sample analysis, a 
second prep was prepared with [1.2 µM] LZD73 and [1 µM] 58mer DNA containing 
one CREB site (5’-ATGACGTCAT-3’) in the middle of the sequence.  [1 µM] CREB 
site DNA in Enteropeptidase buffer was used as the background measurement for this 
analysis.  The CD analysis for this sample is shown in Figure 2.11B.  The 58mer 
DNA sequence is provided in Appendix 1 and is also depicted in Figure 3.4.  
 
Figure 2.11 CD analysis of LZD73 protein.  (A) LZD73 protein alone [1.2 µM] in 
enteropeptidase buffer (see above) and (B) LZD73 [1.2 µM] with 58mer CREB DNA [1 µM]. 
The two dips at 210 nm and 220 nm are indicative of α-helical folding.  An increase in the 
220 nm signal is observed upon DNA addition, indicating additional folding as the protein 





The signal produced is typical of α-helices, indicating this protein exists 
primarily in that folded form. This is in agreement with our design and can be 
viewed, in combination with the highly soluble nature of LZD73 and LZD87, as a 
positive indication that the proteins exist in a well-folded state even in the absence of 
DNA.  Additionally, it is observed that the signal at 220 nM increases when CREB 
DNA is added to the sample. This indicates that there is additional folding into α-
helices upon binding to DNA, which is in concurrence with prior analysis of other 
bZip peptides.  This data does not indicate whether the protein exists as a dimer when 
free in solution (not bound to DNA), but previous results on leucine zipper peptides 
suggested that the monomers are predominantly unfolded. This data strongly supports 
the notion that our design has led to a protein that folds correctly.  The next step of 




















3 Chapter 3: Binding Characterization of DNA Looping 







Eletrophoretic Gel Mobility Shift Assays (EMSAs) were used to provide an 
initial characterization of the protein:DNA interactions. In order for a looping protein 
to effectively function, it must be able to stably bind two separate DNA fragments 
simultaneously in a “sandwich complex”.  To assess this potential we designed an 
EMSA assay that would form an “asymmetric” sandwich, meaning the two bound 
DNA fragments would have significantly different lengths. For comparison, a known 
single binding peptide consisting of the bZip domain from GCN4 was used as a 
control (generously provided by Jim Maher from his neutral wild type control ‘PAA’ 





3.2 Materials and Methods 
The Electrophoretic Mobility Shift Assay (EMSA), also known as a gel shift 
assay, is a common technique for characterizing protein:DNA interaction.  DNA 
migrating through a polyacrylamide, driven by an electric field, will migrate slower if 
protein is bound to it. As a proof of concept for our protein design, we required an 
assay to show that our DNA looping proteins possess an ability to bind two 
independent strands of DNA in a stable structure termed a “sandwich complex”.  Any 
looping protein will, by definition, be required to bind DNA in this manner.  This 
chapter describes the EMSA experiments performed to evaluate whether the 4HB and 
LZD proteins can bind two separated helices of DNA and form a stable sandwich 
complex.   
3.2.1 Binding/Ligation Buffer Formulation 
The confirmation of a sandwich complex will constitute a successful first 
round of characterization.  Further analysis to demonstrate looping will involve a 
series of ligation dependent experiments that necessitates a buffer compatibility 
between EMSA binding experiments and T4 DNA ligase activity.  The NEB provided 
buffer for T4 DNA ligase consists of 50 mM Tris HCl pH 7.5, 10 mM MgCl2, 10 mM 
dithiothreitol, 1 mM ATP.   This formulation was an initial source of difficulty.  The 
GCN4 bZip peptide would not shift in EMSA studies when the MgCl2 concentration 
was at 10 mM, and T4 DNA ligase would not function at our initial binding buffer 
concentration of 2 mM MgCl2.  Additionally, our initial binding buffer contained a 




the ligase enzyme itself from adsorbing onto the walls of the polypropylene reaction 
tubes, but this combination of BSA, MgCl2 and DTT led to a rapid precipitation.   
Optimization by trial and error was done to identify a buffer formulation that 
would allow DNA binding and ligation to occur in a precipitate free solution.   A 
successful binding/ligation (B/L) buffer formula was achieved using 50 mM Tris HCl 
pH 7.7, 4 mM NaCl, 4 mM KCl, 4 mM MgCl2, 2 mM ATP, 0.2 % Glycerol, 100 
µg/mL BSA, 10 mM DTT, and 0.01 % NP40 (IGEPAL).   
3.2.2 Sample Preparation and Gel Analysis 
All dilutions were done using 1X B/L buffer.  For EMSA assays, protein and 
DNA were added in equal volume (5 µL each), mixed by pipette, and incubated for 
10 minutes at room temperature.  2 µL of 6X DNA loading dye was added, and the 
sample was immediate loaded onto the gel. 
 
Three EMSA gel formulations were utilized over the course of these experiments:  
 
10 % acrylamide (75:1 acrylamide:bis-acrylamide) was used with a TBE buffer (50 
mM Tris HCl pH 8.1, 50 mM boric acid, 1 mM EDTA) on the 25mer EMSA with the 
4HB (Figure 3.1).  Binding buffer (used prior to the Binding/Ligation buffer 
formulation) was composed of 10 mM Tris HCl pH 7.8, 1 mM EDTA, 5 mM KCl, 5 
mM MgCl2, 0.01 % NP40, 50 µg/mL BSA).  The gel was run for 1 hour at 400 volts.   
 
7 % acrylamide (75:1) was cast with TBE buffer (50 mM Tris HCl pH 8.1, 50 mM 
boric Acid, 1 mM EDTA), which was also used as the running buffer, for the 145 bp 




decided that this binding buffer should be compatible with T4 DNA ligase (ATP 
dependent) so the buffer had been reformulated to the B/L described above.  The gel 
was run for 1 hour at 400 volts.   
 
To resolve the EMSA sandwich complexes sufficiently, an acrylamide percentage 
lower than 1 % (75:1) was required.  Below 6 % at 75:1 acrylamide:bis-acrylamide, 
the polymerized product begins to exist in a liquid state.  To get around this problem 
required the invention of a new hybrid gel approach that combined 0.5 % agarose 
with either 4 % or 5 % acrylamide.  The formulation used in the EMSA gels in 
Figures 3.5, 3.6, and 3.7, the 58mer/30mer sandwich complexes, is as follows: 5 % 
acrylamide (75:1), 0.5 % agarose, run in 1X TBE Buffer (50 mM Tris HCl pH 8.1, 50 
mM Boric Acid, 1 mM EDTA).  Gels were run for 1 hr at 300 volts. 
 
The gels were dried on filter paper and were used to expose storage phosphor screens 
overnight.  The images were captured using the Storm 860 Phosphorimager 
(Molecular Dynamics) scanner and visualized using ImageJ.   
3.3 Results 
3.3.1 EMSA Analysis of 4HB mutants 
The migration of a sandwich complex in an acrylamide gel should differ 
greatly from that of a single DNA fragment with a singly bound protein.  By 
comparing the control GCN4 bZip binding behavior to the 4HB proteins, it should be 
evident whether the designed proteins are binding DNA according to design.  GCN4 




CREB and the pseudo-palindromic AP1 site DNA (Koldin, Suckow, Seydel, 
Wilcken-Bergmann, & Müller-Hill, 1995). For the initial 4HB construct EMSA 
experiments, 23 bp DNA fragments containing the AP1 binding site (5’-
ATGACTCAT-3’) were end-labeled with 32P using polynucleotide kinase (PNK) 
with γ-32P-ATP and held at a constant concentration of 5 nM. Each of the four 
peptides was then added in at 5 nM, 25 nM, and 100 nM monomer concentrations 
(see Figure 3.1). Assuming a tetrameric folding of the peptide, the molar ratios of 
protein to DNA would therefore be 0.25:1, 1.25:1, and 5:1, respectively.  The results 
demonstrate that both 4HAR and LZAR, two of the three insoluble mutants, 
aggregate along with the DNA and result in a well shift.  The intensity of this well  
            
Figure 3.1 EMSA of the 4HB construct with 23 bp DNA (5’-AGTGGAGATGACT-
CATCTCGTGC).  DNA concentration was held constant at [5 nM] in all lanes while the 4 
proteins (4HAR, 4HEE, LZAR, and LZEE) were added in a concentration gradient of 5, 25, 
and 100 nM. The well shifts observed are likely a result of insoluble aggregates.  The 





aggregate is proportional to the protein concentration and there is no distinguishable 
population that migrates into the gel.  This suggests that 4HAR and LZAR are not 
folded into a stable tetramer and that their insolubility is not enhanced by the low 
concentration.  Work with these two mutants was not continued.   
The 4HEE and LZEE mutants however did form stable DNA-bound 
complexes that migrated as distinct populations in the gel shift assay.  The two 
populations observed in the Figure 3.1 could either be sandwich complex or perhaps 
singly bound 23mer and doubly bound 23mer.  In order to make sense of the binding, 
the GCN4 bZip single binding control protein was used to further characterize the 
binding pattern. Figure 3.2 illustrates the binding of GCN4 bZip peptide of increasing 
concentration with a 145 bp DNA fragments containing one CREB site.    
  
                          
Figure 3.2 EMSA of 145 bp DNA with GCN4 bZip single binding protein control.  The 145 
bp DNA with single CREB site DNA (5’-ATGACGTCAT-3’) was held constant at 1 nM 





This gel illustrates the sequential binding events as the peptide concentration 
is increased.  This DNA fragment only contained one CREB binding site, meaning 
additional binding must be through non-specific interactions.  This is likely due to the 
low ionic strength of the binding buffer (4 mM NaCl, 4 mM KCl, 4 mM MgCl2). This 
formulation was similar to that used in prior binding characterization studies, 
however those also contained 200 mM guanidinium and 10 % glycerol (Chan, 
Fedorova, & Shin, 2007; McDonald et al., 2007). The ionic strength of this buffer is 
therefore much higher due to Guanidine HCl salt existing entirely as the guanidinium 
cation (pKa 13.6) in solution.  Mimicking this buffering component would not be 
feasible because of the previously mentioned compatibility requirement for T4 DNA 
                         
Figure 3.3 EMSA of LZEE peptide and 177 mer DNA.  The 177 bp DNA [1 nM] contains 
both the CREB site (5’-ATGACGTCAT-3’) and Inv-2 site sequence (5’GTCATATGAC-3’) 
separated by 115 bp. The DNA was held constant while the LZEE peptide was titrated in at 





ligase.  To determine whether LZEE was binding as a sandwich complex or as a 
singly bound peptide, further analysis with a 177 bp DNA fragment was performed 
using a similar protein gradient approach.  
This gel revealed a similar pattern for binding (see Figure 3.3) as seen in the 
GCN4 bZip control (Figure 3.2) indicating LZEE did not forming a sandwich 
complex with DNA.  Because 4HEE and LZEE behaved nearly identically in the 
original 23 bp EMSA, both can be ruled out as potential DNA looping proteins. 
3.3.2 EMSA Analysis of LZD Proteins 
In order to demonstrate the existence of a stably bound sandwich complex an 
EMSA technique was employed where the CREB and Inv-2 specific site would bind 
DNA fragments of considerably different lengths (58 bp and 30 bp, respectively).    
    
Figure 3.4 (A) Image illustrates the asymmetrical sandwich complex that would confirm dual 
binding of the LZD protein.  By radiolabeling only one of the two double helical DNA’s at a 
time, the resulting mixed population will be uniquely produced in both sets of parallel 
experiments. (B) 58mer and 30mer DNA with CREB and Inv-2 binding sites.  The sequence 





This EMSA method, termed the asymmetric approach, should unequivocally 
demonstrate a sandwich population by 32P labeling one of the fragments while 
titrating in the unlabeled counterpart.  If this was done in parallel – the 58mer is 32P 
labeled while the 30mer is not, or vice versa –a unique population should emerge in 
both sets that can only be explained by the asymmetric sandwich complex.  Figure 3.4 
illustrates this parallel approach to sandwich formation. 
The GCN4 bZip peptide and the reverseGCN4 peptide were used as single 
binding controls in this experiment.  All three proteins were subjected to identical 
procedures.  The GCN4 bZip EMSA is shown in Figure 3.5, while the reverseGCN4 
is shown in Figure 3.6, and LZD73 in 3.7.  
The GCN4 bZip peptide exhibited tight binding to the CREB DNA and weak 
binding to the Inv-2 site DNA at low concentration of peptide (Figure 3.5 lanes 2 and 
7). However, at higher concentration it showed significantly more promiscuous 
binding than the reverseGCN4 C-terminal single binding control (see Figure 3.6).  As 
seen in Figure 3.5 lane 4, the 58mer CREB DNA shifts to two additional populations 
upon the addition of excess protein and with the Inv-2 site DNA shifts to one 
additional population (lane 9). This non-specific binding can be competed off with 
addition of the cold competitor and does not lead to a unique population that would 
be expected if an asymmetric sandwich complex were forming.  The non-specific 
binding is likely a result of the low ionic strength of the buffer system used.  This is 
seen as unavoidable given the requirement that this buffer must serve as both a 





        
Figure 3.5 EMSA of GCN4 bZip single binding control with DNA fragments of 58 bp 
(CREB site) or 30 bp (Inv-2 site). The peptide contains one DNA binding region at the N-
terminus of the peptide and shares amino-acid identity with the wild-type bZip region of 
GCN4. The radiolabeled DNA fragments were held constant at [1 nM] (lanes 1-5 CREB 
58mer, lanes 6-10 Inv-2 30mer) while the GCN4 bzip protein was added at [2 nM] and [5 
nM].  Unlabeled DNA fragments with opposite binding sites were then added at [2 nM] as 
cold competitors (lanes 3,5,8,10).   
 
The reverseGCN4 demonstrates tight binding to the Inv-2 site  (lanes 7 and 9) 
and this binding cannot be competed off by the addition of the CREB site DNA (lanes 
8 and 10).  The peptide does exhibit binding to the CREB DNA (lanes 2 and 4), 
though this is of lower affinity than for Inv-2 DNA.  This difference in affinity is 
confirmed by competing CREB DNA off with Inv-2 DNA (lane 3 - completely, and 
lane - partially), but not vice versa (lanes 8 and 10).  This result of binding CREB 




            
Figure 3.6 EMSA of reverseGCN4 bZip single binding control with DNA fragments of 58 bp 
(CREB site) or 30 bp (Inv-2 site). The peptide contains one DNA binding site at C-terminus 
of the peptide.  The radiolabeled DNA fragments were held constant at [1 nM] (lanes 1-5 
CREB 58mer, lanes 6-10 Inv-2 30mer) while the GCN4 bzip protein was added at [2 nM] and 
[5 nM].  Unlabeled DNA fragments with opposite binding sites were then added at [2 nM] as 
cold competitors (lanes 3,5,8,10). 
 
binding sites.  This gel clearly shows single binding of the C-terminal protein binding 
domain with both CREB and Inv-2 site DNA, with a stronger affinity for the Inv-2 
site. 
Figure 3.7 shows the EMSA results from LZD73 binding, which proved far 
more interesting.  It should be noted that our predicted asymmetric EMSA product 
only appears, as expected, in lanes 3, 5, 8, and 10.  The band can be seen paired with 
the cartoon representation that matches the asymmetric graphic from Figure 3.4.  The 




                   
Figure 3.7 EMSA LZD73 with DNA fragments of 58 bp (CREB site) or 30 bp (Inv-2 site). 
The radiolabeled DNA fragments were held constant at [1 nM] (lanes 1-5 CREB 58mer, lanes 
6-10 Inv-2 30mer) while the GCN4 bzip protein was added at [2 nM] and [5 nM].  Unlabeled 
DNA fragments with opposite binding sites where then added at [2 nM] as cold competitors 
(lanes 3,5,8,10).  The emergence of the sandwich complex in lanes 3,5,8,and 10 confirms the 
dual binding capability of the LZD protein 
 
however here it leads to a variety of sandwich complex products that have been 
interpreted in the figure.  What is important about this gel is that the non-specific 
sandwich complexes (either 58mer-58mer or 30mer-30mer) are converted to the 
asymmetric sandwich (illustrated in Figure 3.4) as expected upon addition of the 
unlabeled competitor.  The existence of this predicted sandwich complex product is a 




3.4 Discussion of Results 
3.4.1 The 4HB Mutant Binding 
In order for DNA looping to occur, two DNA binding events must take place.  
The 4HB mutants relied on a tetrameric design where complex folding was required 
in order to incorporate two DNA binding sites.  The EMSA results shown in Figure 
3.1 indicate that LZEE and 4HEE do not fold into tetramers with dual binding 
capacity.  The single binding pattern of LZEE (the only soluble mutant) in Figure 3.3 
paralleled that of the GCN4 bZip control protein (Figure 3.2), from which we can 
argue that it folded as a dimer.  This is quite easy to imagine since the major domain 
of the protein is from GCN4’s dimeric leucine zipper.  Investigations into the nature 
of coiled-coil folding and oligomerization have identified a trigger sequence for the 
dimerization of GCN4 (Kammerer et al., 1998). The theory of trigger sequences has 
been further resolved and recently applied broadly to all bZip proteins and additional 
states of oligomerization (Ciani et al., 2010; Steinmetz et al., 2007). The dimerization 
trigger sequence for GCN4 was identified as –YHLENEVARLKKL-.  In our 4HB 
peptide constructs, this comprises the 13 aa immediately prior to the 7 aa linker.   
Additionally, the 7 aa linker of LZEE –VEELLSK- was taken directly from the 
leucine zipper region of GCN4 (aa257-aa263 from the wild type protein, or aa68-
aa74 in our peptides) and the heptad repeat maintains V and L at the a’ and d’ 
position within the zipper.  Furthermore, the leucine zipper motif of hydrophobic 
residues at the a’ and d’ positions is maintained during the transition to and then 




folding of leucine zipper oligomers (cited above), the conclusion that LZEE and 
4HEE simply folded into dimeric form is well founded. 
While the insoluble nature of 4HAR and LZAR likely meant they simply 
formed unstructured aggregates, LZEE and 4HEE clearly had defined structure and 
could bind DNA. While the failure of the 4HB design represented a major setback for 
this project and resulted in work with these four proteins being suspended, it can be 
argued that the solubility of LZEE was a small, albeit orthogonal, success in its own 
right.  We demonstrated that the DNA binding capacity of LZEE was not diminished 
by elongating the wild-type GCN4 leucine zipper.  This proves, at the very least, that 
a bZip dimer can be engineered at the C-terminal and still readily bind DNA at the N-
terminal end.  This result would prove useful during the redesign process. 
3.4.2 The LZD Mutant Binding 
In order for DNA looping protein to function, it must be capable of tightly binding 
two distinct helices of DNA.  LZD73 demonstrates this feat as seen in Figure 3.7.  Of 
concern is the promiscuous binding of the N-terminal GCN4 binding domain.  This 
binding behavior can likely be attributed to the low ionic conditions in the binding 
buffer (4 mM NaCl, 4 mM KCl is well below standard cellular conditions).  In order 
to provide a biochemical analysis of DNA looping with the LZD proteins, it was 
decided that ligase-mediated ring-closure experiments would be utilized.  This 
forward looking plan required the binding buffer to serve in both EMSA assays and 
ligation reactions with protein binding, and the resulting low salt was a necessary 
compromise.  The NEB provided T4 DNA ligase buffer contains 50 mM Tris HCl, 10 




not accidental. During the experiments that sought to reconcile the buffer conditions 
it was observed that ligase activity drastically decreased above 20 mM NaCl.  T4 
DNA ligase activity is essential to the experiments in chapter 4 and 5, so it was 
decided that the 4 mM NaCl and 4 mM KCl formulation was acceptable.  Care would 
be taken to control the protein:DNA ratios and concentrations would be kept as low 


















4 Chapter 4: Length Dependent Loop Formation Using Ligase-







In forming, DNA loops must overcome two free energy hurdles.  The first is 
entropic, where the likelihood of two ends of DNA meeting in a loop decreases as the 
distance between them increases.  This factor is independent of the geometry of DNA 
and as such is in contrast with the second factor, the torsional rigidity of DNA double 
helix. For large rings >2000 bp, the rigidity plays virtually no part in loop but as the 
DNA decreases in length, this factor becomes considerable (Horowitz & Wang, 
1984).  The LZD proteins were designed to investigate this property of DNA as it 
pertains to protein-mediated looping.  The characterization of LZD found that the two 
ends could independently bind to DNA.  In principle, if such dual binding is possible, 
then looping must also be possible providing the length of DNA in the loop is 
   
Figure 4.1 Overview of dimerization bridged by sandwich complex formation (lengths not to 
scale). This illustrates the concept of using sandwich complex formation to increase the 
likelihood of forming dimer products.  At the moment of ligation, a transient loop is formed if 




sufficiently long that the torsional rigidity in not too high an energetic obstacle.   In 
order to address whether looping could occur, we used a ligation based technique 
where DNA bound in sandwich complex with protein demonstrates enhanced 
dimerization versus diffusion controlled DNA-only.  Figure 4.1 illustrates the concept 
behind these experiments.   
This approach has been previously utilized to show that c-Myc can form a 
weakly stable tetramer (Ferré-D'Amaré et al., 1994).  This method is difficult to 
interpret quantitatively because of the multitude of sandwich complexes that can 
form.  But this approach does allow for the qualitative assessment of whether a loop 
formed, since at the moment of ligation (if it is sandwich complex facilitated) a 
transient loop must occur.  The confirmation of a transient loop was very useful in 
defining what length ranges to explore with more quantitative methods.  
4.2 Materials and Methods 
All reagents were purchase from Fisher Scientific with the exception of 
[α32P]dATP, which was purchased from either Perkin Elmer or MP Biomedicals, and 
the dNTPs, which were purchased from NEB.  All enzymes were purchased from 
New England Biolabs (NEB).  Qiaquick PCR Cleanup kits were purchased from 
Qiagen.   
4.2.1 PCR Generation of Variable Length Fragments. 
The variable length DNA fragments were constructed using PCR from a 
plasmid template (pIx Dimer – previously referred to as pVx6 II) containing the Inv-2 




reverse primers were used to adjust the length of the fragments.  The reverse primers 
also contained an XhoI restriction site at a region 5’ to the region that would anneal to 
the template, while the forward primer, provided by IDT, lacks a 5’ Phosphate, which 
prevents ligation of that end.  Figure 4.2 illustrates how the plasmid template was 
used to produce the variable length fragments (A) and lists the primers used in the 
experiment (B).  The complete sequences of the 3 PCR products can be found 
 
Figure 4.2 Plasmid diagram (A) and primer usage (B) illustrating the construction of the three 
Ix DNA fragments with Inv-2 binding sites.  Underlined primer regions indicate the portion 
of which anneals to the template while the XhoI sites (CTCGAG) are in BOLD. 
 
in Appendix 1. The DNA was body radiolabeled during synthesis by incorporating 
[α-32P]dATP into the reaction.  Based on the molar ratio of [α-32P]dATP to unlabeled 
dATP and the number of dA residues per DNA fragment, the concentrations for the 
final products could be calculated using scintillation counting.  This method of direct 
measurement, as opposed to using scintillation fluid, is referred to as Cerenkov 
counting (Plesums & Bunch, 1971).   
A PCR master mix of all reagents except primers was prepared as follows: 45 
µL 5X Phusion buffer, 12.25 µL dATP [2 mM], 12.25 µL dTTP [2 mM], 12.25 µL 




µL H2O, 9 µL [α-32P]dATP  [3.33 µM], 2.5 µL Phusion polymerase (2 U/µL).  At 
running conditions, the dNTP’s were [100 µM] each and the [α-32P]dATP  was 
[0.1332 µM] for a ratio of 750:1.  Primers were diluted to [2 µM] and 5 µL of forward 
primer was added to each tube and 5 µL of the corresponding reverse primer was 
added to the appropriate tube along with 40 µL of the master mix (50 µL total), for 
final primer concentrations of [200 nM] each.  The reaction protocol was as follows:   
Initial denaturation: 99 °C for 3 min 
Cycle (33 repeats) 
1. 95 °C for 30 sec 
2. 59 °C for 20 sec 
3. 73 °C for 20 sec 
After PCR, but prior to XhoI digestion, the samples were subjected to a 
Qiaquick PCR cleanup column to remove polymerase and unincorporated 
nucleotides, and eluted in 50 µL of H2O.  This step was essential for producing a high 
yield of ligatable DNA fragments with functional XhoI 5’ overhangs.  The samples 
were digested with 20 units XhoI for 1 hr in 57 µL of NEB Buffer 2 (10 mM Tris-
HCl, 50 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, pH 7.9) at 37 °C.  The 
digested products were purified by PAGE (7 % acrylamide, 75:1) run in TBE for 1 hr 
at 400 V, excised from the gel and then eluted overnight in 500 µL of 50 mM 
potassium acetate, 1 mM EDTA, pH 7.1.  The eluted samples were concentrated to 
100 µL by speedvac and then subjected to a second Qiaquick PCR cleanup column.  
The samples were eluted in water and quantitated using Cerenkov counting.  UV260 




eluted products, 50 µL, would require 2X dilution to fill the cuvette and the amount 
of DNA at that volume would not lead to an accurate reading given the large 
background noise introduced by residuals from the gel extraction process. 
4.2.2 Ligation Procedures 
DNA samples were diluted to 5 nM in B/L buffer.  Protein samples were 
diluted to 125 nM in B/L Buffer.  The proteins used in the experiment were the 
GCN4 bZip peptide, the reverseGCN4 peptide, LZD73 and LZD87.  A DNA-only 
control was also performed.  22 µL of DNA [2 nM] and 22 µL protein [125 µM] were 
mixed (1X B/L was used in place of protein for the DNA-only sample) and were 
allowed to equilibrate for 10 minutes at room temperature.  4 µL was removed for the 
time 0 sample then 10 µL of T4 DNA ligase (NEB) was added (15 U/µL in B/L 
buffer).  The final concentrations during ligation were 2 nM DNA, 50 nM Protein (a 
12.5:1 protein(dimer):DNA ratio), and T4 DNA ligase at 3 U/µL.  The reaction was 
allowed to proceed at room temperature.  At time points 2.5, 5, 10, 30, 60, 150, 300, 
and 1080 minutes, 5 µL of the ligation mix was removed and the reaction quenched 
by adding 3 µL of 2 mg/mL Proteinase K in B/L buffer that was brought to 50 mM 
EDTA.  The high concentration of EDTA in the Proteinase K mix should chelate the 
Mg2+ thus inactivating T4 DNA ligase very rapidly. 
The quenched samples were incubated at 37 °C for 15 minutes to allow 
Protease K to digest the added proteins and ligase.  The samples were then stored at 
80 °C until reaction was complete (the 1080 minute samples reacted overnight).   
The samples were resolved on a 6 % acrylamide gel (75:1) in TBE buffer with 




loading dye (30 % glycerol, 0.25% bromophenol blue, 0.25 % xylene cyanol, in H2O) 
was added, the samples mixed and then loaded onto the gel. The gel was run at 100 V 
(5 V/cm) for 4 hr.  The gels were dried and exposed to a storage phosphor screen.  
The images were acquired using the Storm Phosphorimager and the bands were 
quantitated using the volume integration function in ImageQuant (Molecular 
Dynamics).  The fraction of dimer product formed was calculated by dividing the 
dimer population by the sum of the dimer and the monomer population.  This value 
was plotted as a function of time using Prism 5.  
 
4.3 Results 
The three DNA lengths used would lead to loops with lengths of 208 bp (Ix1), 
314 bp (Ix2), and 610 bp (Ix3).  The sandwich complex formation holds two DNA 
molecules in close proximity in space and it may also align the XhoI ends to each 
other.  Both of these effects will lead to enhanced kinetics of ligation.  Therefore and 
increase in the initial ligation rate compared to the DNA-only sample (or single 
binding peptide controls GCN4 bZip or reverseGCN4) can only be attributed to 
protein induced loop formation or network formation.  
The protein and DNA concentration used were chosen based on initial runs that 
were optimized by trial and error.  DNA concentrations that were too low would not 
yield much if any product because of second order nature of the reaction.  At excess 
protein concentrations, sandwich complexes will not form.  On the other hand, 




noticeably different results form DNA-only controls, because most of the DNA is not 
bound.   
The gels showing the dimerization of Ix1, Ix2, and Ix3 are presented in 
Figures 4.3, 4.4, and 4.5 respectively.  The Complete data set for the dimer product 
fraction versus time in plotted in Figure 4.6.  This graph shows the complete data set.  
The initial dimerization rates for LZD73 (blue) and LZD87 (purple) are clearly 
greater than for DNA-only (red) and the single binding protein controls reverseGCN4 
(green) and GCN4 bZip (teal).  This represents a successful result and suggests that 
both LZD73 and LZD87 can form DNA loops as short as 208 bp. 
 
Figure 4.3 Dimerization of Ix1 DNA (29 bp blunt end to Inv-2 site, 104 bp Inv-2 site to XhoI 
end).  Five dimerization experiments for 4 protein samples and a DNA-only control are 
shwon. An increase in the rate of formation of dimer product (ligated dimer) indicates an 
interaction between one protein and two DNA fragments.  Time points are given in minutes.  
The ON (overnight samples) were allowed to react for 1080 minutes 
 
It should be noted that the GCN4 bZip sample shows evidence of DNA 
degradation.  This is likely due to the presence of a contaminating DNA nuclease.  
Previous work with this protein sample and DNA consisted of gel mobility shifts in 





Figure 4.4  Dimerization of Ix2 DNA (29 bp blunt end to Inv-2 site, 207 bp Inv-2 site to XhoI 
end).  Five dimerization experiments for 4 protein samples and a DNA-only control are 
shown. All conditions and interpretations are the same as for Ix1 ligation. 
 
onto a gel.  The gel then acted to separate the DNA from the contaminant and 
therefore any degradation was minimal and not recognized.  The extended incubation 
time for this experiment (the ON –overnight- samples were incubated for 18 hours)    
 
Figure 4.5 Dimerization of Ix3 DNA (29 bp blunt end to Inv-2 site, 305 bp Inv-2 site to XhoI 
end).  Five dimerization experiments for 4 protein samples and DNA-only control are shown. 
All conditions and interpretations are the same as for Ix1 ligation. It should be noted that the 
lanes ran aberrantly in this gel because a long bubble formed beneath the gel during the run.  
This did not affect the ability to quantitated the populations. 
 
allowed for excessive degradation as seen in Figures 4.3, 4.4, and 4.5 for GCN4 bZip 
samples at times of 60 minutes and beyond.  Additionally, if the putative nuclease had 




of the two strands to be ligated. This degradation likely accounts for the diminished 
reaction rate observed in the GCN4 bZip samples as well as the overall decrease in 
dimer formed at the 1080 minute time point observed in Ix2 and Ix3 ligation. 
Subsequent extended incubation tests (not shown) with DNA and the GCN4 bZip 
peptide sample confirmed that the DNA nuclease activity is an element of the protein 
sample and does not reflect contamination unique to this experiment.   
4.4 Discussion of Results 
The benefit for using a low concentration of DNA [2 nM] is that with low DNA 
concentration, dimerization by diffusion of DNA-only is very slow.  The rate of 
ligation in sandwich complex is accelerated is and only if the effective concentration 
of the two XhoI ends near each other is greater than the bulk DNA concentration. The 
protein concentration was chosen empirically to maximize the dimerization product 
observed at the given DNA concentration of 2 nM.  This allowed for better contrast 
among the rates of LZD73 and LZD87 bound samples and non-sandwiched samples.  
The Inv-2 site DNA was chosen for this experiment because the EMSA results 
indicated that both ends would bind to this sequence at the given concentrations.  The 
concentration ration (protein:DNA) was increased above that of the EMSA 
experiments in chapter 3 based on trial and error of previous dimerization kinetics 
attempts (not shown). The Ix DNA alone was preferable to using a mixture of CREB 
and Inv-2 site DNA because it allowed for a homogeneous DNA sample.  A similar 
set of fragments was made with the CREB site, but despite being identical in length to 
the Ix counterparts, they had slightly different mobilities in PAGE analysis, probably 





Figure 4.6 Sandwich complex-mediated dimerization kinetics.  Graphical analysis of the 
fraction of dimer formed versus time for three lengths of DNA.  The DNA samples Ix1, Ix2, 
and Ix3 were graphed showing all data points (A, B, and C, respectively).  A second set of 
graphs, showing the data points for only the first ten minutes, depicts the initial enhancement 
of dimerization for Ix1, Ix2, and Ix3 samples (E, F, and G, respectively) with LZD 73 and 
LZD 87. 
 
together resulted in different mobilities for each of the expected dimers of Ix-Dx, Ix-
Ix, and Dx-Dx.  Although this heterogeneous DNA experiment did show a qualitative 
increase in dimer product with LZD proteins (not shown), the analytical difficulties of 
parsing the data from three sets of products was easily avoided with the approach 




A shortcoming of this method is that multiple protein binding conformations 
are possible, because the DNA is asymmetrical in length with respect to the position 
of the binding sites.  The palindromic nature of the binding sites allows for one of two 
binding orientations at both ends of the protein.  As seen in Figure 4.7, the sandwich 
complex can exist in one of two possible conformations, in either a cis or a trans 
state.  We proposed that for shorter length DNA in the cis form, ligation is possible 
when the binding sites orient in the same direction.  In the trans form, however,  
 
                                 
Figure 4.7 Proposed binding orientations for the sandwich complexes.  If the binding 
orientation of a loop more closely resembles the trans form it may require longer lengths of 
DNA to observed products in the cyclization work in chapter 5.  
 
the sites orient away from each other thus preventing ligation at short DNA lengths.  
This may account for the lower overall dimerization rate observed in LZD73 and 
LZD87 in the Ix1 set relative to the Ix2 and Ix3 sets.  If the XhoI digest ends are 
being held apart while the protein-mediated sandwich complex formation exists in the 




quality of DNA is different between the three sets.  Fortunately, this explanation does 
not limit the information gained from the analyzing the amount of ligated product 
versus time.  If XhoI digestion efficiency was lower for the Ix1 DNA relative to the 
other two then the Ix1 DNA will have a lower effective concentration. If the DNA has 
more defective and therefore non-ligatable ends, there will also be an overall lower 
fraction formed. The support for this latter case is that the overall rates for the DNA-
only control and reverseGCN4 are also slower with Ix1 than with Ix2 or Ix3.  GCN4 
bZip is of little value for comparison because of the DNA nuclease contamination.     
The enhanced ligation seen for sample with either LZD73 or LZD83 is very 
encouraging.  It can be concluded with confidence that the close proximity induced 
by sandwich formation leads to a drastic increase in dimerization versus DNA 
diffusion controlled.  Again, because of the multiplicity of possible sandwich 
complexes, the result does not provide much quantitative information regarding the 
geometry and stability of the loop, only that a loop transiently existed at the moment 
of ligation and is thereby stable enough to exist a significant fraction of the time. This 
clearly warrants further evaluation of looping with LZD73 and LZD87.  In the next 
chapter, DNA cyclization will be used to investigate looping.  This sensitive 
technique can provide information regarding the stability of DNA loops and can 














5 Chapter 5: Topoisomer Product Distribution in Protein-







The evidence of transient loop formation in the dimerization experiments was a 
furtherance of our goal of demonstrating a stable looped complex with our engineered 
proteins. However, to fully characterize the protein induced looping and gain 
pertinent data regarding loop shape and stability, a more precise method is needed.  
DNA cyclization is well suited for this because it allows for differentiation between 
subtle topological changes.  Two series of experiments were designed to first identify 
a minimal DNA length for looping with our proteins and then demonstrate periodicity 
in the results that is dependent on the helical repeat.  This chapter is summarized by 
an upcoming manuscript submission (Gowetski, D., Kodis, E., Kahn, J. Manipulation 






5.2 Principles Behind DNA Cyclization in Topology Studies 
DNA ring closure (ligase-mediated cyclization) experiments have frequently 
been used to study the thermodynamics behind DNA flexibility in solution (Geggier 
& Vologodskii, 2010; Kahn, Yun, & Crothers, 1994; Rybenkov, Vologodskii, & 
Cozzarelli, 1997).  Any particular DNA fragment, of sufficient length, with two 
complementary overhangs will, when exposed to T4 DNA ligase in the presence of 
ATP, react in one of two ways. The first is bimolecular, where a dimer product is 
formed, and the second is unimolecular, where a cyclized product is formed.  The 
ratio of rates of formation of cyclized monomer circle over the formation of dimeric 
products is referred to as the j-factor and the mathematics describing this concept 
were actually worked out a few years before the structure of DNA was proposed 
(Jacobson, Beckmann, & Stockmayer, 1950). The technique was later applied to 
DNA by Shore and Baldwin (Shore, Langowski, & Baldwin, 1981).  Recent work has 
used the cyclization technique to support the theory that DNA is far more flexible at 
short lengths that previously accepted (Cloutier & Widom, 2004; 2005). In these 
experiments, DNA was shown to cyclize with far higher frequency than would be 
expected at the given length (<110 bp), thus challenging the consensus on j-factors at 
these short lengths, although this claim has been met with skepticism (Du et al., 
2005).  But the approach has application beyond the determination of bending and 
twisting of naked DNA.  As illustrated in Figure 5.1, when a linear fragment of DNA 
closes into a ring, any topological change, such as a change in twist or writhe, will be 




entrapment of form allows for a quantitative assessment of the energy differences of 
supercoiling (sc) behind the topological distributions (ΔLk) between populations of 
DNA (Horowitz & Wang, 1984).  It also traps a record of any structural changes 
induced by ligands bound to the DNA that have topological effects. This in vitro 
approach offers the potential to indentify and characterize stable DNA loops that may 
be formed with our proteins.   
                 
Figure 5.1 Illustration depicting the conformational changes that may lead to different  
topoisomer products.  A change in the writhe (ΔWr) can be captured if the cyclized product 
has two double helix strands that approach each other prior to ligation (Strand Placement).  
The DNA can also produce topological variants depending on whether the strand ends may 
under or over-twist in order to align the overhangs prior to ligation, resulting in a ΔTw. 
 
When a protein binds a DNA fragment and the complex forms a loop, the 
protein is forcing a conformational change on the nucleic acid polymer.  This change 
can be in the form of twist or writhe, or a combination of both depending on the 
relative energetics of different deformations.  When the looped DNA is cyclized by 
DNA ligase, the conformational change in twist and/or writhe will result in a change 
in the linking number relative to closure without protein-induced looping (relaxed 





Recall from Section 1.2 that circular DNA of equal length but with different 
linking numbers can be easily resolved by electrophoresis in the presence of an 
intercalating agent such as chloroquine.  If cyclization demonstrates an absolute 
change in linking number and this change is dependent on the periodicity of the 
helical repeat between binding sites, we can claim with confidence that the change in 
Lk is the result of a stable loop.  If a loop can form but is unstable and quickly falls 
apart then the probability that ligase would cyclize a looped geometry rather than a 
relaxed unlooped geometry is low and the product distribution would appear 
unchanged from the DNA-only control.  If, however, the loop is stable, then  
                              
Figure 5.2 Topological changes, in the form of ΔWrithe and ΔTwist induced by protein 
looping, can manifest in different topoisomer populations.  The changes in Wr and Tw result 
from direct geometric changes introduced by the protein and also from the bending and 
twisting of the unbound DNA required for loop closure. The figure legend (right) applies to 
all ligation-based cartoons. 
 
it will be the most frequent form and should be readily captured by the enzymatic 
reaction.  Additionally, a positive change in linking number would be a stronger 
indication of looping than a negative change.  This assertion arises for previous work 
demonstrating that GCN4 binding induces a slight untwisting (53° ± 3°) of the DNA 




(Hockings, Kahn, & Crothers, 1998).  It is also quite possible that both a +1 and -1 
topoisomer will result because a stable loop may form by either undertwisting (-1 
topoisomer) or by overtwisting (+1 topoisomer) the DNA between the protein’s two 
binding sites.  Though a topological change should arise from looping, it is not proof 
of a DNA loop.  
The telltale sign of looping, as demonstrated by the in vivo work of Tom 
Record and Benno Müller-Hill (LacI), as well as Robert Schleif (AraC), is to 
demonstrate that a given result is dependent on the periodicity of the helical repeat 
(Bellomy et al., 1988; Lobell & Schleif, 1991; Müller et al., 1996).   
In order to fully characterize the looping capacity of the LZD proteins, we 
designed two sets of cyclization experiments.  The first investigated the loop stability, 
as measured by the appearance of topological changes, over a range of DNA 
fragments where the binding sites were spaced between 153-448 bp.  The second 
sought to demonstrate a periodic dependency in the resulting topoisomer changes by 
cyclizing a series of DNA fragments of equal length that contained incremental 
spacing variations between the CREB and Inv-2 sites over two helical repeats (435-
458 bp).  Combined, these two methods were used to provide a quantifiable approach 
to characterizing DNA looping geometry induced by the LZD proteins.   
5.3 Materials and Methods 
5.3.1 Design of Variable-Length DNA Constructs For Cyclization  
A series of DNA fragments of variable lengths was constructed to determine 




construction of the plasmids used in this experiment and the primers used.  Six 
plasmids were constructed to contain both the CREB binding site (5’-
ATGACGTCAT-3’) and the Inv-2 binding site (5’-GTCATATGAC-3’) separated 
over a range of 153-448 bp.  PCR was used to synthesize cyclization fragments that 
could then be digested with XhoI at both ends to produce two complementary 
overhangs that would permit cyclization.  Two sets of primers were used to allow two 
possible lengths from the binding sites to the XhoI ends.  This translates to the 
effective size of what we have referred to as the “outer loop”, the size of the DNA 
fragment between the two binding sites that is covalently closed by T4 DNA ligase. 
The distance between the CREB and Inv-2 sites, the DNA involved in looping, we 
refer to as the “inner loop”.  Primers were designed to produce external loops of 212 
bp (primers 100 and 101) or 414 bp (primers 200 and 201).  Complete sequences for 
the PCR generated fragments and primers used can be found in Appendix 1.  Table 1 
lists the DNA fragments used and provides a breakdown of the overall lengths and 
binding site spacing separation.  
DNA Construct Length (bp) Helical Turns (Lk°) Binding Site Separation (bp) 
Vx(153)200 567 54.0 153 
Vx(202)200 616 58.7 202 
Vx(254)200 668 63.3 254 
Vx(310)200 724 69.0 310 
Vx(376)200 790 75.2 376 
Vx(448)200 660 62.8 448 
Vx(448)100 862 82.1 448 
 
Table 1 DNA fragments constructed by cloning, PCR and XhoI digestion.  The total length, 







Figure 5.3 Plasmids used for producing the Vx(153-448) DNA fragments for cyclization.  
CREB sites are identified as solid black boxes, while Inv-2 sites are white boxes.  PCR 
followed by XhoI digestion of the products will produce DNA fragments with variable inner 
loops of 153-448 bp and constant outer loops of 212bp (primers 100 and 101) or 414 bp 







5.3.2 Design of Vx 435-458 Binding Site Separation Fragments 
 
To demonstrate the periodic dependence of the topoisomer populations on the 
helical phasing of the binding sites, a series of 10 plasmids were constructed that 
contained both the CREB binding site (5’-ATGACGTCAT-3’) and the Inv-2 binding 
site (5’-GTCATATGAC-3’) separated incrementally over a range of 435-4548 bp.  
Primers 200 and 201 from the previous PCR protocol were used to incorporate the 
two XhoI sites at the ends of the PCR products.  Figure 5.4 illustrates the plasmid 
          
Figure 5.4 Schematic of the ten plasmids used to construct the Vx(435-458) DNA fragments 
by PCR.  CREB sites are identified as solid black boxes, while Inv-2 sites are white boxes.  
PCR with identical primers followed by XhoI digestion of the products will produce DNA 
fragments with a constant length of 862 bp with variable inner loops of 435-458 bp and 
variable outer loops of 427-404 bp.  Underlined regions of the primers represent the 




design and placement of the primers with respect to the binding sites.  In order to 
maintain a constant length for the ten fragments (so that the DNA-only controls 
cyclize identically), we varied the number of base pairs between the Inv-2 binding 
site and XhoI end.  The “internal loop” (between the binding sites) varied     
            
Figure 5.5 Cartoon illustration depicting the Vx(435-458) phased binding site experiment. 
The variable length inner loop and outer loop are illustrated.  Total lengths for these ten 
fragments was held constant at 862 bp. 
 
between 435-458 bp. To maintain a constant length of 862 bp for all ten fragments, 
the Inv-2 to XhoI length was varied from 224-201 bp, respectively, while the length 
from the CREB site to its corresponding XhoI end was held constant at 204 bp.  






Vx(435)200 862 435 41.4 40.7 
Vx(438)200 862 438 41.7 40.4 
Vx(440)200 862 440 41.9 40.2 
Vx(443)200 862 443 42.2 39.9 
Vx(445)200 862 445 42.4 39.7 
Vx(448)200 862 448 42.7 39.4 
Vx(450)200 862 450 42.9 39.2 
Vx(453)200 862 453 43.1 39.0 
Vx(455)200 862 455 43.3 38.8 
Vx(458)200 862 458 43.6 38.5 
 
Table 2 DNA fragments used in Vx(435-458) cyclization.  The total length is held constant at 
862 bp while the binding site is spaced between 435 and 448 bp. The helical repeats of both 






The constant length of 862 bp (82.1 helical turns) and the sequence near-identity 
between fragments differing only in the placement of the Inv-2 site should ensure that 
these DNA fragments behave identically in the DNA control reactions.  Table 2 lists 
the 10 fragments used in this experiments.  The full sequences of the PCR products 
can be found in Appendix 1. 
5.3.3 Assembly, Radiolabeling, and Purification of DNA Constructs  
 
PCR generation of 32P labeled DNA fragments was done using PCR mixture 
protocols as described in the PCR reactions described in the Materials and Methods 
section of Chapter 4, except scaled for more samples. Each PCR reaction was 
performed at 50 µL, though the master mixes varied in volume depending on the 
number of total reactions performed. Additionally, the PCR cycle parameters were 
modified to achieve better yield as follows: 
Initial denaturation: 99 °C for 3 min 
Cycle (33 repeats) 
1. 95 °C for 1 min 
2. 65 °C for 20 sec 
3. 73 °C for 25 sec 
The PCR products were subsequently purified by Qiaquick PCR cleanup kit 
(Qiagen), eluted in H2O (50 µL), and digested overnight with 20 units of XhoI 
enzyme (NEB) in NEB Buffer 2 (57 µL total volume).  The samples were then gel 
purified using 7 % acrylamide (75:1), extracted and further processed by Qiaquick, 




DNA purification section of Chapter 4 Materials and Methods.  The final DNA 
products were in H2O after elution from the second Qiaquick PCR cleanup column 
and were stored at -20 °C. 
5.3.4 Ligase-Mediated Cyclization of Protein-Mediated DNA Loops 
The buffer conditions used in the experiments were identical to those 
described in the Materials and Methods section for the EMSA experiments in Chapter 
3 and the dimerization assay in chapter 4.  All samples were diluted in and all 
reactions took place in B/L buffer.  The stop buffer used consisted of Proteinase K 
(NEB) diluted to 2 mg/mL in B/L buffer that had been brought to 50 mM EDTA to 
chelate the Mg2+ and quench ligase (EDTA was 10 mM upon addition to the 
reaction).   
DNA samples were diluted to 1 nM and protein samples were diluted to 30 
nM in B/L Buffer.  T4 DNA ligase was diluted to 10 U/µL immediately prior to use.  
The proteins used in the variable length (153-448 bp) experiment were the 
reverseGCN4 peptide, LZD73, and LZD87. GCN4 bZip was not used because of the 
putative DNA nuclease contaminant issues observed during the dimerization assays.  
The use of DNA and reverseGCN4 single binding protein as controls was deemed 
sufficient.  The protein and DNA samples were mixed in equal volumes (5 µL each) 
and allowed to equilibrate for 10 minutes at room temperature. The DNA-only 
samples (5 µL) were mixed with 5 µL B/L buffer to maintain consistent 
concentration.  T4 DNA ligase diluted in B/L buffer (10 U/µL) was then added in 
equal volume (5 µL) to the samples and DNA and mixed by gentle pipetting.  The 




protein, and T4 DNA ligase at 3.3 U/µL.  The reaction was allowed to proceed at 
room temperature for 60 minutes.  Following ligation some samples were treated with 
BAL 31 DNA nuclease to remove linear DNA from the sample to remove any linear 
multimers background bands that could interfere with analysis of topoisomer 
products. For these samples, 15 µL of 2X Bal-31 reaction buffer was added (2X BAL 
31 buffer is 40 mM Tris HCl, 1.2 M NaCl, 24 mM CaCl2, 24 mM MgCl2, 2 mM 
EDTA pH 8.0) and then 0.25 units of BAL 31 was added to each sample followed by 
mixing by pipetting.  The reaction was allowed to proceed at 30 °C for 30 minutes. 
Following this digestion step, 4 µL of 2 mg/mL Proteinase K in B/L with 50 mM 
EDTA was added and samples were moved to 37°C for 15 minutes.  Samples that 
were not BAL-31 digested had 4 µL of the Proteinase K mix added immediately after 
the 60 minute ligation and the samples were also incubated at 37 °C for 15 minutes to 
digest the T4 DNA ligase and target proteins.  These samples then had 15 µL of the 
2X BAL-31 buffer added (but no enzyme) to increase the ionic strength of the 
solution so it would be suitable for EtOH precipitation, and the make sure that salt 
concentrations were consistent in later steps.  
5.3.5 EtOH Precipitation of Reacted Samples and Gel Analysis 
All samples were EtOH precipitated prior to gel analysis.  To each sample 
(either 30 or 35 µL at this point), 105 µL of 100 % EtOH was added and the samples 
gently mixed by pipetting.  The samples were moved to the -80 °C freezer for 15 
minutes.  They were then centrifuged for 15 minutes in the micro centrifuge at 16,000 
x g at 4 °C.  The supernatant was removed and the pellets were air dried for 3 




bromophenol blue, 0.05 % xylene cyanol, 3 % Ficoll 400, and 10 % glycerol (without 
the high glycerol these samples tended to “float” upon gel loading), and chloroquine 
(7.5 µg/mL) intercalator to resolve the topoisomers.  The samples were moved to a 50 
°C bath for 5 minutes prior to loading to improve resuspension after EtOH 
precipitation.   
Gels consisted of 6 % acrylamide (75:1) in 50 mM Tris HCl, 50 mM boric 
acid, 1 mM EDTA, 7.5 mM NaCl, and 7.5 µg/mL chloroquine.  The identical buffer 
formulation was used as the running buffer. Gels were run at 4 V/cm for 18 hours 
(Vx153-448 samples) or 42 hours (Vx435-458 samples).  The gels were dried and 
then exposed to a storage phosphor screen for at least 24 hr.  The images were 
captured using the Storm Phosphorimager 860. The bands were quantitated using the 
volume integration function on ImageQuant (Molecular Dynamics).  For the Vx435-
458 samples, the fraction formed for each topoisomer population was calculated by 
dividing each Lk population by the sum of all Lk populations. 
 The values were plotted as a function of binding site separation to illustrate the 
correlation between topoisomer populations and the helical repeat of DNA using 
Prism 5.  
5.4  Results 
5.4.1 Formation of Topological Variants for Variable Length DNA 
Constructs Vx(153-448)  
A unique topological shift can be viewed as evidence for the formation of a 




Introduction.  However, there are many alternate reactions that may occur leading to 
other final products.  The first consideration in that even in a system that involves 
DNA looping, it would be unrealistic to assume that all DNA molecules are bound in 
a looped state.  The concentration of protein may not be adequate to ensure complete 
binding saturation, and any loop will be in equilibrium between a looped and 
unlooped state.  If ligase were to react with the DNA that either was not bound to 
protein or only singly bound, the topoisomer product should loop identically to the 
DNA-only control.  The second element to consider would be the formation of a 
sandwich complex (PD2) that could react in one of two ways.  As illustrated in 
Figure 5.6, this event would lead to a bimolecular product or cyclization that is 
independent of the bound protein.  For DNA fragments that cannot loop, this would 
be the predicted result.  In Figure 5.7, the bimolecular products are enhanced to a 
degree in nearly every LZD73 or LZD87 sample.  However, the effect is greatest in 
the Vx(153)200 sample and the Vx(448)100 sample.  In these samples, it is also 
observed that the circular products are diminished relative to the DNA-only control    
               
Figure 5.6 Reaction outcomes that do not give novel topological products:  i. Sandwich 
complex formation leads to enhanced dimerization ii. Protein independent cyclization iii. 
Cyclization is inhibited by looping. iv. Enhanced bimolecular reaction through alternate 
geometry sandwich complex formation.  Enhanced bimolecular reaction can also occur 




because they are being diverted to bimolecular products.  Figure 5.6 (right) illustrates 
the possible products associated with this control fragment with a shortened external 
loop.  
What emerges from the results in Figure 5.7 is that the DNA fragments with 
binding site separations ≤254 bp did not result in the formation of new topoisomer 
products in the presence of LZD proteins (lanes d, e, and f in columns 1, 2, and 3) 
suggesting that looping does not occur at these lengths.  The samples with ≥310 bp 
 
Figure 5.7 Analysis of Vx153-448 cyclization constructs run on a 6 % acrylamide gel with 
7.5 µg/mL chloroquine.  The repeating lane conditions (a-f) are as follows: a. DNA-only, b.  
DNA + ligase control, c. DNA + reverseGCN4 + ligase control, d. DNA + LZD87 + ligase, e. 
DNA + LZD73 + ligase, f. DNA + LZD73 + ligase then BAL-31 digested.  The presence of 
+1 and −1 topoisomers in the LZD added samples (e, f, g) for DNA ≥ 310 bp is indicative of 
looped DNA. 
 
binding-site separation, however, all demonstrated new topoisomer products in the 
form of both +1 and −1 topoisomer products (lanes d, e, and f columns 4, 5, and 6).  
Additionally, the shortened external loop control (condition iii in Figure 5.6, column 
7 of Figure 5.7) did not result in new topoisomer products. We propose that a loop 




oriented away from each other and cannot ligate (Figure 5.6 iii.), supporting the 
theory of the cis and trans orientation is correct (Section 4.3).    
The emergence of +1 topoisomers during the cyclization of fragments where 
the binding sites are spaced ≥310 bp is a very strong indication of protein-mediated 
looping.  If only −1 topoisomers emerged, that could be explained by local untwisting 
at the point of single binding with protein, while the +1 population cannot be a result 
of such a binding event. These results represent a closer step towards a definitive 
demonstration of looping, but they are not conclusive in their own right.  To provide 
an unequivocal answer regarding loop formation with our proteins, the 435-458 bp 
binding-site phasing experiment will be essential.   
5.4.2 Optimized Protein Concentration for Looping 
Protein concentration plays a pivotal role in determining the outcomes in these 
cyclization assays.  The optimal concentration of protein is one where all, or nearly 
all of the DNA is looped and very little of it is free in a sandwich complex with 
protein, or doubly-bound by protein. If the protein concentration was below the 
optimal value then there would exist an unbound portion of the DNA population that 
would be cyclized with the same distribution as the DNA-only controls. This would 
effectively lead to a high degree of background noise in the sample distribution.  
Although this would be uniform throughout the samples (provided the protein 
concentration was held constant) it is still an undesirable and avoidable scenario.  In 
contrast, a protein concentration that was well above the optimal level would lead to 
non-specific binding and double-bound complex formation.  At very high protein 




protein:DNA complexes.  The addition of T4 DNA ligase to such a complex would 
lead to not only enhanced dimerization, but also to multimers of DNA including 
trimers, tetramers, and beyond.   
To evaluate how protein concentration affects the distribution of cyclized 
versus multimerized products, Vx(448) DNA was cyclized in a series of reactions 
where LZD73 concentration was incrementally increased from 4-66 nM while the 
DNA was held constant at 0.33 nM (DNA concentration was kept low to minimize 
sandwich complex formation and reduce bimolecular ligation).   
The gel analysis for protein concentration optimization (Figure 5.8) 
demonstrates an initial increase in the +1 topoisomer (the determinant product) at 
protein concentrations from 4 nM to 10 nM.   This population then begins to decrease 
 
Figure 5.8 LZD73 protein gradients from 0-66 nM combined with 0.33 nM Vx6(448)200 and 
T4 DNA ligase. The +1 topoisomer is the determinant variable for observing looping effects.  
This population increases up to 10 nM and then steadily decrease with LZD concentrations 
above that. The linear products (dimer trimer tetramer) steadily increase with increasing 
protein concentration. Reactions were performed for 45 minutes at 3.3 U/uL T4 DNA ligase 




as the LZD73 concentration increases further.  It is also abundantly clear that as the   
concentration of LZD73 increases, the amount of linear dimer, linear trimer, and 
linear tetramer greatly increase and eventually become the dominant populations 
formed.  Since the linear products are evidence of sandwich complexes (likely non-
specific at high concentrations) and compete with or outright inhibit cyclization, their 
emergence is detrimental to this assay.  It can be concluded that the 10 nM protein  
sample maximizes the +1 and −1 topoisomers, which are the desired populations that 
correspond to looped DNA.  Therefore the reactions of the Vx(435-458) binding site 
phasing were performed at this concentration in good confidence that it is the optimal 
condition. 
5.4.3 Variable Length Vx(435-458) Formation of Topological Variants  
Following the classic in vivo work with the LacI that demonstrated looping by 
showing a correlation between activation or repression and the helical phasing of 
binding sites, the Vx(435-458) experiment sought to leave no doubt regarding the 
ability of the LZD mutants to loop DNA.  The decision to shift the binding sites 
incrementally over two helical repeats around the Vx(448) DNA fragment was not 
arbitrary.  While the results from the previous experiment suggested that looping 
could occur at 310 bp, a more intense signal was observed with the Vx(448) sample.  
Of additional significance was the corresponding size of the external loop formed at 
the moment of ligation.  It seemed a more prudent step to try to keep the internal and 
external loop of comparable size (435-458 bp versus 427-404 bp), because modeling 




              
Figure 5.9 DNA-only cyclization of Vx(435-458) constructs with XhoI cohesive ends. All 
DNA are 862 bp with near identical sequences (see Appendix 1).  6 % acrylamide gel with 
added chloroquine (7.5 µg/mL) allows for separation of topoisomers. The observed 
topological products are assigned to Lk 82 (major) and Lk 81 (minor).   All reactions were 
treated with BAL 31 before electrophoresis. 
 
If this result is to have any merit it must be shown that the DNA-only controls 
do not result in any periodic changes in topoisomer distribution.  Because the lengths 
are all held constant at 862 bp, in the absence of and sequence-dependent bends or 
large changes in composition, all molecules should give identical patterns of 
topoisomer distribution.  Figure 5.9 shows the gel analysis of the 10 DNA-only 
controls in this experiment.   
Graphical analysis of the DNA-only topoisomer distribution versus binding 
site separation (Figure 5.10) shows that the data can be fit to horizontal lines.  For 
these 862 bp DNA fragments cyclized in B/L buffer it was found that the topoisomer 
populations form such that Lk81 accounts for 22 % of the total population, Lk82 
accounts for 78 % of the total population and Lk83 accounts for <0.5 % of the total 





Figure 5.10  The fraction of each topoisomer formed for each of the DNA-only cyclization 
reactions for Vx(435-458).  The data sets can be fit to horizontal lines, confirming that these 
DNA fragments behave identically when cyclized by T4 DNA ligase.   
 
is determined as the sum of the products of linking number values (Lk) by the 
fraction of the population at that Lk.  For DNA-only samples, this value is calculated 
to be 81.76 by the following equation: 
             Lkave = 81 * 0.218 + 82 * 0.778 + 83 * 0.004 = 81.76 
The addition of protein to the cyclization reaction produced a dramatic effect.  As 
seen in Figure 5.11, the topoisomer distribution expands to four topoisomers as 
opposed to two observed for the DNA-only controls.  The expansion of observed 
topoisomers from two to four, however, is not the sole significance of this gel.  When 
comparing the topoisomer distribution to the binding site separation, a pattern 
emerges.  Two DNA-only samples (Vx(448)200 and Vx(455)200) were included in 
this gel (lanes 1 and 2) for comparison.  This experiment was repeated (LZD73 n=5, 





    
Figure 5.11 Protein-induced distribution of topoisomers.  Cyclization of Vx(435-455) 862 bp 
DNA constructs after addition of LZD73 and LZD87 protein. 0.33 nM DNA and 10 nM 
protein is allowed to equilibrate for 10 minutes prior to ligation with T4 DNA ligase. 
Digestion of linear DNA with BAL 31 leads to only cyclized product being present in the 6 % 
acrylamide gel with 7.5 µg/mL chloroquine.  The ligation of looped DNA captures the 
equilibrium as a distribution of topoisomers.   
 
 
separation as seen in Figures 5.12 (LZD73) and 5.13 (LZD87). This representation 
clearly illustrates the helical dependence of the topoisomer distribution.  These values              
were fit to a sum of Gaussians using Prism, and the peaks between each LK 
population were found to be separated by 10.5 bp ± 0.5 bp.  Figure 5.12 depicts the 
results for LZD73 and Figure 5.13 depicts the results for LZD87.  The periodicity 
seen in the topoisomer populations versus binding site separation represents a clear  
demonstration of looping and validates the function of the LZD proteins as artificial 






             
Figure 5.12  Periodicity of topoisomer distributions for LZD73-mediated loops as captured by 
T4 ligase-mediated cyclization of 862 bp DNA (n=5, error bars indicate the standard 
deviation). The DNA-only samples were repeated from Figure 5.10 for comparison.  The 
observed periodicity is fit to a sum of Guassians and the distance between peaks correlates to 
the helical repeat of DNA (10.5 bp).  
 
             
Figure 5.13 Periodicity of topoisomer distributions for LZD87-mediated loops as captured by 
T4 ligase-mediated cyclization of 862 bp DNA (n=3, error bars indicate the standard 





5.5 Discussion of Results 
 
In order to clearly demonstrate looping with our artificial proteins, we devised 
a series of cyclization experiments where DNA looping would alter the topological 
distribution of the cyclized products.  The inner loop length spacing variation in the 
Vx(153-448) experiment sought to identify a minimal looping length range.  By 
demonstrating both ΔLk = +1 and a ΔLk = −1 populations at lengths ≥310 bp, we 
were able to show that our protein can be used to form DNA loops at those lengths.  
The +1 topoisomer production was a clear result of a looping protein inducing 
structural change on the DNA.  If the ΔLk were simply a result of DNA untwisting 
upon single binding, then only −1 topoisomers would form rather than both +1 and 
−1.   In order to unequivocally demonstrate looping as opposed to protein-induced 
overtwisting, we used an approach of phasing the binding sites over two helical 
repeats to show that looping produced a topological change that was dependent on 
helical phasing.  The formation of a loop and then subsequent cyclization of this 
looped DNA fragment resulted in a distribution of topoisomers that can only be 
explained by protein induced changes in DNA writhe (ΔWr) and twist (ΔTw). The 
topology experiment also sets limits on possible loop geometries, as described below.  
5.5.1 Contribution of ΔTwist   
The Vx435-458 experiment surveys the topological fate of looped DNA 
across the span of 24 bp. Because this represents just over two helical repeats, the 
observed pattern clearly repeats itself.  This is reaffirming.  Two of the most 
noteworthy topological distributions to emerge in this pattern of results are those that 




interesting because it so closely resembles the DNA-only sample.  This could be 
explained in one of two ways.  One is that this particular loop is inherently unstable 
and what is observed is simply DNA-only being cyclized by ligase.  The other is that 
the DNA is looped and that the geometry of that loop most closely resembles that of 
relaxed DNA.  The evidence suggests the latter.  For starters, the looped DNA on 
each side of the protein is roughly three persistence lengths long, which means that 
the torsional strain of a twist of 180° or less in a 862 bp fragment is relatively low.  
The DNA-only sample exists as two topoisomers (Lk 81 and Lk 82) when fully 
relaxed, which suggests there is enough torsional freedom to account for up to a full 
twist in 862 bp DNA.  Additionally, the difference between these samples and their 
nearest neighbors in the series is only two and three base pairs.  If a loop is stable at 
438 bp and at 443 bp, is hard to argue that it cannot accommodate the change in twist 
between the two.  Furthermore, a casual glace at the pattern shows that the 
topoisomer distribution is shifting from heavily +1 to −1 and -2 from 438 to 443 bp.  
That this distribution aligns perfectly with the Gaussian fit substantiates the claim that 
this is not an unlooped outlier among the data pool.  The final piece of evidence for 
this set is that there is a near integer number of helical repeats between the binding 
sites (41.9 and 42.9 for 440 and 450, respectively).  This suggests that the DNA does 
not have to twist to align the binding sites as the two approach each other during 
looping.  That the variance of topoisomers emanate away from the two data sets is 
strong evidence that, in these looped populations, the DNA must either over or under 




The second highly interesting data sets, the 435/445/455 repeats, also support 
the argument that ΔTwist plays the dominant role the topoisomer distribution.  The 
support for a ΔTwist theory of distributions comes from the bifurcation of the 
topoisomers into Lk 83 and Lk 81 at these positions. Relative to the 440/450 samples, 
whose internal helical repeat tally is nearly integral, the 435/445/455 set is offset by 5 
bp, which translates to a helical repeat tally that is nearly half-integral.  Because the 
binding sites now face opposite sides of the double helix, as the loop forms, the DNA 
must either over-twist or under-twist in order to align the DNA binding sites with the 
protein.  That the DNA must make assume one of those two conformations is further 
evidence for this distribution being a result of twist variations.   
The 435/445/455 set also uniquely provides evidence that the protein 
concentrations used in this experiment were optimal.  Because Lk82 is the major 
component of the DNA-only, relaxed cyclization, any DNA from the protein-
containing samples would be likely form Lk82 if not looped around protein.  That the 
Lk82 population is nearly non-existent in LZD73 and very minor in LZD87, suggests 
that nearly all DNA was involved in protein binding.  It is clear that all of the protein-
bound loops have substantially DNA deformation higher free energy than relaxed 
because they all deviate away from the most relaxed topoisomer of 82.  The DNA 
deformation is paid for by the favorable free energy of protein binding.  However, 
this is not to say that all DNA is involved in looping.  These samples were BAL 31 
treated which digested any linear DNA so any dimer or trimer would not have been 
visible in this analysis.   However all ten samples have roughly equivalent total 




5.5.2 Contribution of ΔWrithe 
While the effect of ΔTwist in this experiment is clear, the effect of ΔWrithe is 
subtle.  The modeled structure depicted in the chapter on design suggested that 
LZD73 would have a crossover angle that was near 90° while LZD87 would be closer 
to 180°.  While this assay was not able to quantitate the absolute amount of writhe 
induced by the looping protein, a plot of the average Lk versus binding site separation 
(Figure 5.14) reveals that for all but the 443/453 set, the average is greater that the 
DNA-only value of 81.76.   
If the only topological effect of looping were the ΔTwist component, then, 
over the course of one helical repeat, the over-twisting and under-twisting events 
should ultimately average out.  This is not to say that every binding site separation 
should have an Lkave equal to the DNA-only value, but rather that the average of all 
samples within a helical repeat should coincide with the DNA-only value. As seen in 
Figure 5.14, this is not the case.  In fact, each repeat has only one sample with a Lkave 
value less than the DNA-only value and three samples that have a greater Lkave.  We 
ascribe the overall positive change in Lk to be due to positive writhe induced by 
looping 
If the untwisting of the binding event, suggested in Hockings et. al, is taken 
into account there should actually be an overall decrease in the Lkave. This could 
mean that the total ΔWrithe component to this loop is actually greater than the values 
depicted in Figure 5.14.  Additionally, the difference between the two protein samples 




        
Figure 5.14 Weighted average topoisomer distributions were calculated for each Vx 
fragment. The black horizontal line is the DNA-only samples. The positive displacement 
from the DNA-only average and the difference between LZD73 and LZD83 are likely due to 
differences in the writhe induced by the two loops. 
 
quantify this writhe and provide a measurement of the angle between bound DNA 
strands additional experiments will be necessary. One possible such experiment 
would to use FRET to measure the distance between bound DNA stands, which could 




























6.1 Demonstration of an Artificial DNA Looping Protein 
 
Following the example set by Bellomy et al. (1988) and Muller et al. (1996) 
our cyclization assays provided evidence of looping by demonstrating a dependency 
of results on the helical repeat of DNA. While we were clearly capable of forming 
loops, there is a surprising gap between the lower length limit established by our 
assay (310 bp) and that observed with natural proteins.  Specifically, LacI can form a 
loop of 92 bp in its natural lac operon setting and has also been shown to form loops 
as small as 58 bp in an engineered system. This gap of nearly 250 bp is likely the 
result of the inherent flexibility in the LacI protein, allowing it to provide stability to 
the very short loop by conforming to the DNA’s most energetically relaxed form.  
LZD proteins, in contrast, were engineered to avoid this flexibility and therefore any 
structural strain required to form a loop is isolated to the DNA molecule. This was a 
major goal of this project and further work will be needed to exploit LZD’s potential 
as a rigid artificial DNA looping protein.   
6.2 Further Characterization of LZD proteins 
 
6.2.1 Identifying the Minimal Looping Length 
 
The successful engineering of our protein opens up several new avenues of 
exploration.  Initially, further characterization of the looping limits should be 
investigated.  While the results from the Vx(153-448) cyclization work in section 5.3 
identified 310 bp as the shortest length loop to stably form, our results cannot be used 




thorough analysis of loop formation between 200 bp and 300 bp is warranted.  The 
use of the periodic binding site separation approach would be well suited as its results 
are easily interpreted. This would involve significant cloning to produce the plasmid 
templates required, making an alternative method of assembly appealing.   A faster 
approach may be to utilize a modular assembly of the DNA using a combination PCR 
products and covalently linking them together.  It is conceivable that 50 variable 
length looping fragments with 200 to 300 bp binding site separation could be 
assembled this way in less time than it took to clone the original ten plasmid 
templates for Vx(435-458) fragments.  The determination of an explicit lower limit 
would be a tremendous asset in understanding the energy behind DNA looping. 
6.2.2 Measurement of the Relative DNA Binding Angle Using FRET 
 
An additional level of binding site angle characterization could be achieved 
using a FRET based approach to measure the difference between LZD73 and LZD87 
binding orientations.  As seen in Figure 6.1, the placement of FRET donor and 
acceptor molecules on the ends of DNA situated near the CREB and Inv-2 site DNA 
would allow for measurement of their separation.  The relative difference between 
LZD73 and LZD87 could be quantitated to provide a direct measurement of the 
binding angle.  This could be very useful in putting these proteins to use in 
assembling protein:DNA nanostructures as the ability to rotate the bound DNA along 







Figure 6.1 FRET based measurement of binding site orientation.  DNA bulges (PDB:1JRV) 
were used to angle the DNA such that donor and acceptor are closer to each other than if 
simple places immediately next to the CREB and Inv-2 sites.  This would make FRET 
measurement possible for a loop if the two binding sites were on the same DNA fragment, 
having both the CREB and Inv-2 sites.   
 
6.3 General Future Directions 
6.3.1 The Creation of Topological Domains using LZD proteins 
 
Recent work by Fenfei Leng demonstrated that LacI and GalR-mediated loops 




al., 2011).  This was shown individually relaxing two asymmetrically sized loops 
formed in supercoiled plasmid by LacI binding.  The LacI induced looping prevented 
the relaxation of one loop from affecting the supercoiling of the second loop thus  
 
Figure 6.2 Topological domains formed by looping with LZD protein.  A nicking enzyme 
recognition site is located in each of the two looped domains.  Individual nicking should 
results in different amounts of plasmid relaxation because of the asymmetric size of the loops. 
 
establishing topological isolation.  This approach could be readily used to investigate 
LZD looping.  The main benefit to this approach would be an ability to work in a 
more physiological buffer (as opposed to the T4 DNA ligase reaction’s required low 
ionic strength).  Figure 6.2 depicts how this reaction could be performed.  Nt.BbvCi 
and Nt.BspQI are both site-specific DNA nicking enzymes.  Following relaxation 
with these enzymes, the nicks would be enzymatically repaired with a ligase 
(presumably not T4 DNA ligase) and the plasmid resolved by agarose 
electrophoresis. 
6.3.2 Protein:DNA Nanostructures in Two and Three Dimensions 
 
A second major undertaking for LZD would involve its use in the assembly of 
protein:DNA nanostructures.  Binding specificity and rotation of the N and C 




the creation of highly ordered 2 and 3 dimensional nano-structures.  The Kahn lab has 
been working to construct DNA triangle and square nanostructures within which LZD 
specific binding sites could be incorporated to direct protein binding in plane or out of 
plane with the DNA molecule.  By rotating the binding site, though deletion and/or 
additions of bp on either side of the site, it is conceivable that protein:DNA cubes or 
triangular pyramids could be assembled and visualized by Atomic Force Microscopy 
(AFM).    
6.3.3 Introducing a Flexible Hinge into LZD 
 
To provide further proof that protein flexibility plays a large role in stabilizing 
short DNA loops, it would be valuable to introduce flexibility into our looping 
proteins.  The most obvious way to do this would be to incorporate a linker sequence 
in the middle portion of the protein that would consist of random coil.  This could be 
achieved by the used of prolines and glycines in the linker.  Prolines are known to 
break α-helices because of their inability to form appropriate hydrogen bonds and 
glycines allow the least steric hindrance and have greater entropy in the unfolded 
state.  Their incorporation into the LZD peptides would create a hinge region that 
would allow the protein to bend and twist relative to the two binding sites.  Figure 6.3 
depicts how a hinge region within the structure may affect protein flexibility.  If this 
new protein could be used to form loops significantly shorter that LZD73 or LZD87, 
it would be solid evidence that the flexibility of DNA looping proteins is an essential 





                                 
Figure 6.3 LZD Flex design incorporating a proline and glycine rich spacer to confer 
flexibility.  Shown with an optional cysteine disulfide bridge to provide enhance stability of 




DNA loop formation, in nature, is mediated by a variety of looping proteins. 
Among those studied, it has been observed that the protein is inherently flexible and 
can therefore assume different conformations while forming a stable loop.  It has been 
suggested that this protein flexibility adds to the stability of the loop and, based on the 




loops in vivo.  To investigate whether such small loops were forming as a result of the 
protein’s flexibility or if DNA is actually more flexible at shorter length than 
believed, we designed and synthesized a series of DNA looping proteins that were 
inherently rigid.  This work represents the first successful effort in using DNA 
looping proteins in this manner.   
DNA cyclization experiments were used to characterize the geometry of the 
loops formed by capturing different DNA topoisomers that were a result of the 
topological strain induced on the DNA by the looping protein.  Our results showed 
that loops smaller than 310 bp were difficult to form, but above 310 bp formed easily 
and were quite stable.  This is evidence that hypothesis of DNA being inherently 
more flexible than previously believed is not true.   
Furthermore, our artificial DNA looping proteins represent the first 
application of an artificial looping protein to manipulate DNA topology.  These 
engineered proteins will be put to use in assembling protein:DNA nanostructures that 
rely on site-specific interactions.  The demonstration of the coiled-coiled extension 
between LZD73 and LZD87 having an affect on the binding geometry means that, 
with simple protein engineering, this platform can be used to highly orchestrate the 
assembly of three-dimensional structures.  This project represents the first step in 

























All proteins were cloned into the ORF of pRSETA using BamHI and EcoRI 
cohesive ends and the corresponding insertion points in the multiple cloning site 
within the plasmid.  The figure below is a plasmid map of pRSETA indicating the 
pUC origin of replication, the β-lactamase gene (which provides resistance to 
ampicillin), and the open reading frame (ORF) location (which is under the control of 
a T7 promoter). 
 
Appendix 1 Plasmid map of pRSETA.  Genes for the designed proteins were cloned into the 
MCS region of the expression vector (blue) using the BamHI and EcoRI sites. pUC origin 
(green) confers a high-copy number of this plasmid within E. coli, while ampicillin resistance 
is afforded by the presence of a β-lactamase gene (red) 
  
 
Cloned Proteins: ORF and Translated Sequences 
 
BamHI (GGATCC) and EcoRI (GAATTC) sites used for cloning 






















































































































































EMSA oligos– Binding Sites HIGHLIGHTED  
 
Assembled By PCR: 
 

















Annealed using IDT ssDNA oligos 
 






















DNA products for Dimerization Experiments 
 
Binding Sites HIGHLIGHTED  
 






















































































































































































































































































































































































Method Protocol for the AKTA Unicorn program that runs the HiTrap Chelating 
Column (Co2+) for LZD and 4HB mutants.   This program reflects the optimized 
protocol which implements a 0-70 % gradient with elution buffer over a 25 CV (25 
mL) volume.  Early purification work with the 4HB mutants involved a 0-100 % 
gradient over 40 CV. The current approach provides superior protein resolution and 
requires less buffer consumption.   
 
Buffers used for LZAR, 4HAR, and 4HEE: 
 
Equilibration – 10 mM MES pH 6.0, 6 M Guanidine, 0.5 M NaCl, 20 mM Imidazole.   
Elution – 10 mM MES pH 6.0, 6 M Guanidine, 0.5 M NaCl, 0.4 M Imidazole.   
 
Buffers used for LZEE, LZD73, and LZD87: 
 
Equilibration – 10 mM MES pH 6.0, 0.5 M NaCl, 20 mM Imidazole.   
Elution – 10 mM MES pH 6.0, 0.5 M NaCl, 0.4 M Imidazole.   
 
 




¤  Main 
  0.00  Base CV 0.96 {ml} HiTrap_Chelating_HP_1_ml  
¤  0.00  Block  Starting_Conditions 
    Starting_Conditions 
    0.00  Base SameAsMain  
    0.00  AutozeroUV  
    0.00  Alarm_Pressure Enabled 0.3 {MPa} 0.000 {MPa}  
    0.00  Flow 1.00 {ml/min}  




    0.00  ColumnPosition Position2  
    0.00  BufferValveA A1  
    0.00  InjectionValve Load  
    0.00  End_Block  
¤  0.00  Block  Equilibration 
    Equilibration 
    0.00  Base SameAsMain  
    0.00  Flow 1.0 {ml/min}  
    0.00  ColumnPosition Position2  
    0.00  BufferValveA A1  
    8.00  AutozeroUV  
    8.00  End_Block  
¤  0.00  Block  Load 
    Load 
    0.00  Base SameAsMain  
    0.00  InjectionValve Inject  
    0.00  Fractionation 18 mm 8.0 {ml} FirstTube Volume  
    0.00  Flow 1.0 {ml/min}  
    0.00  Set_Mark "Sample Load"  
    (15.00)#Load_Volume  InjectionValve Load  
    15.00  Set_Mark "Column Wash"  
    15.00  End_Block  
¤  0.00  Block  Wash 
    Wash 
    0.00  Base SameAsMain  
    0.00  BufferValveA A1  
    0.00  Flow 1.0 {ml/min}  
    5.00  FractionationStop  
    5.00  End_Block  
¤  0.00  Block  Elution 
    Elution 
    0.00  Base SameAsMain  
    0.00  Fractionation 18 mm 1.0 {ml} TubeNumber[B.1] Volume  
    0.00  Gradient 70 {%B} (25)#Gradient_Length_CV {base}  
    30.00  FractionationStop  
    32.00  End_Block  







Purification LZEE in a single step HiTrap Chelating gradient run 
  
Figure 2.9 (repeated) Analysis of LZEE purification steps using HiTrap chelating affinity 
column purification with Co2+ metal.  The gel analysis shows the whole cell lysis (WC), the 
insoluble pellet, the soluble load, the flow through, and then selected elution fractions B12-
C2, corresponding to approximately [240-260 mM] imidazole, showing the target LZEE 









Purification LZD73 in a single step HiTrap Chelating gradient run 
 
Figure 2.10 (repeated) Analysis of LZD 73 purification steps using HiTrap chalating affinity 
column purification with Co2+ metal.  The gel analysis shows the load, the flow through (FT) 
and selected elution fractions B8 and C3-C8, corresponding to approximately [240-270 mM] 
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